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ABSTRACT
Neurocysticercosis (NCC) is the most common parasitic infection of the central
nervous system (CNS) caused by the helminth parasite Taenia solium (T. solium) and
affects 50-100 million people worldwide. Its clinical symptoms include headache, seizures,
hydrocephalus, epilepsy and stroke. These clinical symptoms can have life-long
detrimental effects. As many as half of the total adult-onset seizures and 10% of the stroke
cases in the endemic areas are attributed to NCC, whereas 20% to 30% of symptomatic
patients display hydrocephalus. Treatment of NCC remains a major challenge as the
severity of the symptoms is thought to be elicited by the degenerating larvae resulting from
therapeutic treatment or normal attrition. Specifically, the inflammatory response in the
CNS detected during symptomatic phase is thought to be responsible for the
neuropathology and underlining cause of clinical symptoms. Interestingly, NCC has a long
asymptomatic phase, typically lasting 3-5 years before the onset of the symptomatic phase.
This asymptomatic phase is characterized by little or no signs of inflammation detected
around the live cysts. Thus it is commonly believed that viable cysticerci induce immune
suppressive effects, and loss of these effects when the parasite dies likely leads to activation
of uncontrolled inflammatory response and neuropathology. Therefore, treatments with
anti- parasitic drugs combined immunosuppressive/ anti-inflammatory factors such as
x

corticosteroids are predominantly used to control the host immune inflammatory response.
However, their longtime use can cause other problematic side effect. The characterization
of the immunoregulatory mechanisms in the CNS during helminth parasitic infection is
critical to develop novel therapeutic targets for NCC, which can aid in finding treatment of
a plethora of chronic neuro-inflammatory diseases as inflammation plays central role in
development of majority of the chronic CNS inflammatory/autoimmune diseases.

The severity of the symptoms is associated with the intensity and chronicity of the
local immune response in the CNS, use of a mouse model is essential to perform kinetic of
analysis of the entire infection process. Because T. solium is not infectious to mice, use of
Mesocestoides corti (M. corti), a relative cestode, has allowed for a more controlled study
of the entire infection process, and to better characterize the immune response in the CNS
microenvironment. Importantly, analysis of the infected CNS in the murine NCC model
paralleled results obtained with brain specimens from NCC patients showing release of
glycan antigens that are uptaken by host immune cells in the parasite infected CNS of
humans and mice. In this regard, multiples researchers had indicated that glycans from
pathogens, including helminths, act as pathogen-associated molecular pattern molecules
(PAMPs), which are knowns to be recognized by C-type lectin receptors (CLRs) through
their carbohydrate recognition domains (CRDs) and function as important pattern
recognition receptors (PRRs). We, therefore, hypothesized that M. corti larvae in the CNS
release their antigens glycoconjugates molecules which induce the expression of specific
xi

lectin receptors (LRs) such as galectins. The LRs may play important role in regulating the
immune response and pathology during NCC.

Parasites, particularly helminths, tend to shift the balance of immunity to a Th2 type
of response, and it is likely that Th2 immunity evolved in response to infections with these
parasites. The Th2 response activates or expands alternatively activated macrophages (M2
macrophages) which are associated with suppressive activity. The development of M2
macrophages is thought to be crucial in establishment of chronic parasitic infections as they
express various negative signaling accessory molecules to downregulate the proliferation
of activated T cells, and promote healing and tissue remodeling (1-3). In this regard,
previous studies involving the mouse model of NCC showed the presence of macrophages
with M2 phenotype in the CNS microenvironment. Moreover, a reduction in CNS levels
of M2 macrophages in STAT6-/- mice undergoing NCC is correlated with widespread tissue
damage and greater mortality (4). This is exciting as M2 macrophage mediated antiinflammatory/ neuro protective functions could be important in nervous tissue repair as
well as containment of neuropathology in myriad neuro-inflammatory diseases. However,
the specific role of these M2 cells during NCC infection still remind to be determined.

The tegument in helminths such as T. solium and M. corti is dynamically responsive
to changing host environments or immune attack in the CNS. During CNS infection of both
these parasites, glycan antigens from the rapidly released in the CNS. Interestingly the
xii

glycan antigens containing terminal galactose and galactosamine (detected by the lectin
IB4) is rapidly released (1-2d p.i.), and it is almost absent after 1 wk of infection. This was
correlated with differential upregulation of the Galectins (Galectin-3, -7, and -9), a family
of the galactose specific LRs, in the CNS during murine NCC. The aim of the studies is to
study the specific roles of galectin 3, galectin 7, and galectin 9, in regulation of immune
functions in the CNS microenvironment during murine CNS infection.
Here we report that M2 macrophages in the parasite-infected brain display abundant
galectin-3 expression. Disease severity was increased in Galectin 3-/- mice correlating with
increased neurological defects, augmented cell death and, importantly, massive
accumulation of neutrophils and M2 macrophages in the CNS of these mice. Because
neutrophil clearance by efferocytosis is an important function of M2 macrophages, we
investigated a possible role of galectin 3 in this process. Indeed, Galectin 3 deficient M2
macrophages exhibited a defect in efferocytic clearance of neutrophils in-vitro.
Furthermore, adoptive transfer of M2 macrophages from Galectin 3 sufficient WT mice
reduced neutrophilia in the CNS and ameliorated disease severity in parasite-infected
Galectin 3-/- mice. Together, these results demonstrate for the first time a novel role of
galectin 3 in M2 macrophage function in neutrophil turnover and resolution of
inflammatory pathology in the CNS. This likely will have implications in
neurocysticercosis and neuroinflammatory diseases.
Analysis of helminth-infected mice revealed an abundant expression of Galectin 7
(Gal 7) that recognize galactose moieties in brain endothelial cells. The Galectin 7 -/- NCC
xiii

mice displayed a reduced accumulation of M2 macrophages in the parasite-infected brain.
This reduction in M2 macrophage numbers in the CNS was correlated with an increased
neuropathology and shortened survival. The use of adoptive transfer of fluorescently
labeled cells demonstrated a decreased influx of M2 macophage into the CNS of helminthinfected NCC brains. The use of in-vitro transmigration assay conclusively demonstrated
a key function of Galectin 7 expressed on endothelial cells in centrally regulating M2
macrophage entry into the CNS. The results are highly significant as the BBB restricts the
flow of both cells into the brain, and the fact that galectin-7 regulates M2 macrophage
extravasation into the CNS could be of great importance how to contain neuropathology in
CNS infection.
Galectin 9 was the first to be upregulated as well as at a relatively high level in M2
macrophage. Parasite-infected Galectin 9-/- mice displayed significantly increased
susceptibility to parasite infection, despite a similar parasite burden in the CNS compared
to infected WT mice. The accumulation of macrophages, γδ T cells, αβ T cells, or B cells
in the brains of parasite-infected Galectin 9-/- mice was similar to the WT mice. Moreover,
AAMs which play a profound protective role in murine NCC were observed an increased
level in infected WT and Galectin 9-/- mice. Instead, the parasite-infected Galectin 9-/- mice
exhibited a massive neutrophilia in the CNS and an increase in neutrophil-associated
neuroinflammation. These results suggest that galectin 9 may be involved in controlling
and resolving neutrophilia and inflammation, however, not by efferocytosis. For the first,
we showed in the possible correlation between the presence of Galectin 9 and neutrophilia
xiv

in NCC infection. Further experiments need to be done to determine the specific
mechanism by which Galectin 9 is involved in this process.
In toto, our studies make an important contribution in establishing the novel
protective mechanisms of M2 macrophages functions in the CNS pathological conditions.
Our studies provide a better understanding of the immunopathogenesis of NCC which
should lead to new therapeutic strategies in other CNS inflammatory disorders as well.
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CHAPTER I

INTRODUCTION
Neurocysticercosis: Clinical Symptoms, Epidemiology, and Burden to Society
Neurocysticercosis (NCC), is the most common parasitic infection of the Central
Nervous System (CNS) caused by the larvae stage metacestode of the zoonotic tapeworm
Taenia solium (9-11). The most frequent clinical manifestation associated with NCC are
seizures, hydrocephalus, strokes, and symptoms associated with increased intracranial
pressure (12, 13). Particularly, strokes, seizures and late-onset epilepsy associated with
NCC have devastating effects on the well-being of infected people and socio-economic
development in affected communities (12). NCC accounts for 70-90% to seizures cases
and 4%-12% of the total stroke case in endemic areas (12, 14, 15)
NCC is considered as a major public health problem because it contributes to more
than 50,000 deaths worldwide every year (12, 14-17). The incidence of NCC is most
common in developing countries of Asia, Africa, and Latin America, where this disease is
considered to be endemic (17). NCC used to be rare in developed countries. However, the
recent increase of travel to endemic areas as well as immigration from endemic places
likely have contributed to the ever increasing incidences of NCC reported in developed
countries (18, 19). In the United States, NCC is mostly found to be prevalent in a Hispanic
population. More than 1000 new cases are diagnosed every year in the Southwest region
1

of the USA, where NCC account for more than 2% of neurological admission.
Life Cycle of Taenia Solium
The life cycle of T. solium is complex, which involves a larval stage (metacestode)
and an intermediate host (pig) and human as the only known definitive host (Figure. I-1)
(17-20). NCC is transmitted to humans through ingestion of contaminated food, mainly by
eating raw/under-cooked larvae infected pork meat. Upon ingestion, metacestode reaches
the small intestine and attach to the intestinal wall. The adult worm develops in the small
intestine by forming segments called gravid proglottids. The eggs in these proglottids are
self-fertilized and released into the environment, where they can survive for many months
before entering another host. Pigs ingest T. solium eggs contaminated food or water in
endemic areas. Once the eggs reached the intestine of the pigs, they transformed to an
invasive form called oncospheres. Oncospheres can cross the intestinal wall and reach
different tissues of the host through the body fluid. In the tissues, they transform into
cysticerci in a period of 3 weeks to 2 months (12, 14, 16, 17). The infection cycle continues
when the humans eat undercooked pork infected with T. solium.
In human’s small intestine, embryo releases the oncospheres due to the action of
gastric juices. The oncospheres hatch and cross the intestinal mucosa. They can migrate
and established in muscles, subcutaneous connective tissues, CNS, eyes, liver and other
organs, where they mature into cysticerci and cause pathogenesis. To migrate to striated
muscles, liver, and other tissues, where they develop into cysticerci. In humans, when the
parasite lodges in the CNS, the cysts can cause serious illness resulting in
neurocysticercosis. (Figure. I-1).

2

Figure I- 1.

The life cycle of Taenia solium.

Neurocysticercosis is the result of the ingestion Taenia solium’s cyst. Human becomes
infected either by ingesting contaminated food or autoinfection. In the cause of
autoinfection, cysts are passed to the environment by an infected human and re-enter the
infected body where they migrate to the central nervous system (CNS). Once in the brain,
the eggs differentiate into oncosphere which matures into cysticerci which into
neurocysticercosis. In the other hand, eggs can also contaminate vegetation in the
environment where they last for months until, a pig which is the intermediate host, feed
into it and become infected. Inside the animal, eggs migrate into the intestinal wall where
they differentiate into oncosphere and migrate the muscle where they mature into
cysticerci. Human becomes infected by eating contaminated meat where the cysticerci
migrate to the brain and induce neurocysticercosis.
3

Type of Neurocysticercosis
Inactive Neurocysticercosis: Inactive NCC represents the cases in which
only cysts or only trace residues of the cysts are visible by neuroimaging studies.
Parenchymal calcifications are the most common form of inactive NCC. Some patients
with inactive NCC reveal the presence of hydrocephalus (14).
Active intra-parenchymal Neurocysticercosis: Intra-parenchymal is the
most common form of the disease, which involves the parenchyma of the cerebral
hemispheres. Presence of lesion in the parenchyma commonly detected, particularly at the
gray matter-white matter junction. Intraparenchymal NCC patients present seizures in most
patients as well as headaches and hypertension (12, 20). Many patients with
intraparenchymal NCC may resolve the infection in few years (12, 20). Whereas many
others develop cysticercal encephalitis, another form of intra-parenchymal NCC present in
young adolescents. Untreated patients are more likely to develop severe neurological
disorders
Extra-parenchymal neurocysticercosis
Ventricular neurocysticercosis: About 10 to 20% of symptomatic patients
will develop this type of NCC. The cysts are predominantly found in the ventricles and
associated with the obstruction of the cerebrospinal fluid (CSF) flow (12, 20). Whereas
minor percentage of patients with subarachnoid cysticerci display meningeal signs due to
the presence of cyst(s) in the subarachnoid spaces (12, 20).
Pathogenesis of NCC
The intensity of the immune response is thought to play the most significant role in
the pathogenesis of NCC. The disease severity also is depended on other factors, including
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the number of parasites, the stage of the parasite, size, location in the CNS, and duration
of infection (21).
Duration of infections:
Duration of parasite infection of the CNS is a critical determinant of NCC severity
and disease outcome. The infection process in the CNS of NCC patient can be broadly
defined in three different phases. In the first phase of infection, the parasite thought to enter
the CNS and establish itself by evading the host immune responses. However, direct
evidence regarding the initial clinical symptoms and immune responses in the CNS
microenvironment is minimal. The second phase is the asymptomatic phase typically
lasting from 3 to 5 years after infection of the CNS. During the asymptomatic phase, the
host does not display any clinical symptoms thought to be due to viable cysticerci induce
immune suppressive effects. This phase is characterized by little or no signs of
inflammation detected around the live cysts (5, 7, 8, 14, 17). Because of technical
limitations involved, the immunopathogenesis of asymptomatic phase is primarily
established by analyzing the nervous tissue of patients who have died due to other comorbidities other than the disease itself. The third phase is the symptomatic phase in which
the parasite degenerates and releases parasitic molecules into the surrounding tissue
causing a wide range of clinical symptoms caused by the resulting inflammatory responses
of the host (14). Indeed, it is commonly believed that the viable cysticerci induce immune
suppressive effects and loss of these effects when the parasite dies likely leads to activation
of pathogen resulting in uncontrolled inflammatory response and neuropathology (5, 7, 8).

5

Stage of the Cysts
Previous studies using magnetic resonance imaging (MRI) and computed axial
tomography (CT) had shown parasites go through different stages after entering the CNS
(12, 14, 22). The first state is the vesicular stage, where the live parasites induce immune
suppressive/ regulatory effects with little to none inflammatory response detected in the
CNS microenvironment (18, 20). The second stage is the colloidal cysticerci, where there
is a presence of gelatinous material in the cyst fluid. During this stage, the parasite is in the
dying process and surrounded by a thick collagen capsule (21-24). The third stage is the
granular nodular stage in which the cyst starts to contract, and the walls are transformed
into coarse mineralized granules followed by necrosis (21-24). The last stage is the nodular
calcified stage when the cyst has died and collagenous structures are formed by
calcification of the cyst (21-24).
Immune response in patient undergoing NCC due to helminth infection of the CNS
General and immunological features to helminth infections
Helminths parasites are multicellular eukaryotes that often cause acute and chronic
pathologies. The mechanisms of host defense that control microbial infections are broadly
divided into two categories, innate and adaptive immune responses. Innate immune
responses represent the first line of host defense and constitute a multifaceted and rapid
response to pathogens. It is induced by the interaction of pattern recognition receptors
(PRRs) on host cells with conserved pathogen-associated molecular patterns (PAMPs)
(25). Such interactions result in the development of host Th1 type inflammatory responses
that play an important role in the elimination of the organism (25, 26). However, helminth
parasites have evolved to co-exist in the host and induce compensatory responses often
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leading to the inability of the host to eliminate the parasite (25-27). Parasites, particularly
helminths, tend to shift the balance of immunity to a Th2 type of response.
Immunological features in patients with neurocysticercosis:
In humans for a long period of time after the infection of the CNS, the host remain
asymptomatic. The direct evidence on the kinetic of host-pathogen interaction in the CNS
microenvironment involved in the sequential progression from asymptomatic to
symptomatic stage remains to be clearly understood. However, correlative studies strongly
suggest that the asymptomatic stage is associated with the presence of the live parasites in
the CNS. As the absence of clinical symptoms in infected people coincides with a lack of
detectable inflammatory response in the CNS, it has been assumed that the viable cysticerci
induce immune suppressive effects to evade the immune response (4, 28). A number of
immunomodulatory mechanisms the live parasites use to invade the host immune system
include suppressing lymphocyte activation (27, 29). T. solium inhibits both the classical
and alternative pathways of complement activation by the release of the molecules
paramyosin (binds to C1q) and taeniaestatin (30, 31). Lymphocyte proliferation and
inflammatory cytokine production are mitigated ex vivo (32). During this asymptomatic
phase of infection, even the PBMCs stimulated with T. solium antigens produce T helper
(Th2) 2 cytokines such as IL-4, IL-5, and IL-13 (33), suggesting an anti-inflammatory
response prevails during the symptomatic phase. These live parasite-mediated immune
suppressive/ anti-inflammatory mechanisms could be critical for parasite survival and to
co-evolve with the host to establish chronic infections. In contrast, the analysis of CNS
tissue specimens from NCC patients reveals that the immune response consists of an overt
Th1 phenotype (32) or a mixed Th1, Th2, and Th3 phenotype depending upon the absence
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or presence of granuloma formation (10, 23). Moreover, the Th1 cytokines are detected in
higher concentration in the cerebral spinal fluid (CSF) of symptomatic NCC patients vs.
asymptomatic patients (32). Although direct evidence that the Th1 inflammatory response
contributes to the neuropathology is limited, treatment of NCC patients with corticosteroids
help to control Th1-inflammatory response along-with neuropathology and disease
severity (10, 32). However, the appropriate immune responses that are required to control
the infection or the CNS inflammatory pathology in human patient are largely unknown.
In this regard, the majority of studies in NCC are focused on T-cell mediated immune
responses, possibly due to the presumed role of Th1 cells on the immunopathogenesis.
Nevertheless, macrophages around the metacestode in the CNS of humans with
symptomatic NCC display a low expression of MHC-II molecules, although it appears to
be higher in cells located further away from the parasite (34). Indeed, Downregulation of
MHC-II in macrophages by regulatory T cells (Tregs) and Th2 cells have been shown to
play an important role in establishing chronic helminth infections with limited
inflammatory pathology in their hosts (27). Owing to the critical roles of macrophages and
microglia in both innate immune and adaptive immune effector pathways in the CNS,
identifying their phenotypes and their associated functions in NCC is essential for
understanding the disease process.
Murine Model of NCC
Examining brain specimens from patients that have undergone emergency
craniotomies, have been critical to characterize the immune response in the CNS
microenvironment in NCC and the associated pathology. As the severity of the symptoms
is associated with the intensity and chronicity of the local immune response, use of a mouse
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model is essential in order to allow for a kinetic analysis of the infection process in the
CNS with a more controlled experimental setup. Attempts to develop animal models using
T. solium to mimic host-pathogen interaction have failed in several laboratories as it does
not infect the CNS naturally. Other Taenias such as T. crassiceps do not infect the CNS of
mice through the fecal-oral route as occurs naturally during T. solium infection in human.
Attempts to develop a CNS infection by intra-cranial injection of these parasites failed in
many laboratories as the metacestodes displaced most of the nervous tissue due to their
large size. Although T. solium infects the CNS naturally in pigs, the approach is not cost
effective. Moreover, it is difficult to do a mechanistic study in infected pigs in laboratories
setting to understand the kinetics of immunopathological events in the CNS during the
entire course of infection (35). Many other laboratories had used the artificial infection
caused by Taenia crassiceps cysticerci which is injected into the abdominal cavity of mice.
This model has been useful to understand the impact of immune, sexual and endocrine
factors on the disease, and to study the efficacy of anti-parasitic drugs for cysticercosis.
However, it does not allow to study NCC (35, 36) as the intraperitoneal environment barely
resemble human CNS condition (35).
We and Judy Teale’s laboratory at the UTHSCSA/ UTSA have been using another
closely related cestode, Mecestoides corti (M. corti), with a known life cycle similar to T.
solium, to study the kinetic analysis of the events in CNS microenvironment in nice. The
life-cycle of M. corti involves two hosts. The parasite is believed to ingested by terrestrial
arthropods. An intermediate host such as mouse and lizard consume arthropod carrying M.
corti (37, 38). Once inside the animal, the oncosphere develops into mature larvae. A
definitive host such as dog, cat or skunk, consume the larvae, intermediate host. The larvae
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develop into mature tapeworm releasing eggs in the definitive host for the life-cycle to
continue (38). Owing to these remarkable similarities in life cycles of both M. corti and T.
solium, murine model of NCC was developed by injecting M. corti intracranially. In
laboratory, M. corti metacestodes are maintained by serial intraperitoneal inoculations of
mice. Murine NCC is developed by injecting M. corti metacestodes i.c. in 3-5 wk old mice
at the junction of the superior sagittal and the transverse sutures to avoid penetration of the
brain tissue. During the first 24 hrs of infection, most of the metacestodes are found in the
leptomeningeal space. Depending upon the duration of the infection and the type of host
responses elicited, the distribution of M. corti metacestodes parallels that of T. solium as
the parasite localizes in the subarachnoid space, ventricular areas and parenchyma (9, 38).
In murine NCC, the first cells to infiltrate the brain are large numbers of macrophages, and
T cells followed to a lesser extent by neutrophils, T cells and B cells. However, as observed
in symptomatic NCC patients, the cytokine response of infiltrating cells in the CNS during
M. corti infection is a mixed Th type response with higher IL-2, IL-12, IL-15, IFN-γ, and
TNF-α indicative of a Th1 type of response (4, 9, 32, 39, 40), along with IL-4, IL-13 and
IL-10 (Th2 type) detected in the CNS albeit at a relatively lower amount. Most importantly,
similar to human NCC, the degree of inflammation in the CNS increases correlates with
disease severity (4, 9, 32, 39, 40). Thus, murine NCC provides an important model for
understanding the human disease which should aid in understanding the kinetics of the
immunopathological events in the CNS microenvironment and the development of new
therapeutic strategies.
Similar to human NCC, the degree of inflammation in the CNS correlates with the
disease severity in murine NCC (10, 41). In these mice infected i.c. with M. corti, the Th1
10

cytokine response in the CNS microenvironment is mounted by γδ T cells (10, 42, 43). Use
of γδ T-/- mice revealed that the inflammatory response by them contribute to infiltration
of immune cells into the brain (30, 39) and enhance neuropathology and disease severity
(10, 30). Thus, in the chronic stage of both human and murine neurocysticercosis,
manifestation of the TH1 inflammatory response is the main cause of disease severity and
mortality. Importantly, the murine NCC provides an important model for understanding
the human disease which should aid in understanding the kinetics of the
immunopathological events in the CNS microenvironment and the development of new
therapeutic strategies.
Protective versus detrimental correlates in murine NCC
The last decade of research has demonstrated that Toll-like receptors of the innate
immune system play an important role in eliciting host inflammatory responses (44, 45).
In murine NCC, all the TLRs (TLRs1-13), except TLR5 are upregulated and differentially
expressed among the various nervous tissue and infiltrating immune system cell types (46).
Moreover, in the absence of MyD88, a central adaptor molecule associated with the
signaling pathway induced by all the TLRs activation except for TLR3, infiltration of
immune cells into the CNS was reduced. MyD88-deficient mice infected with M. corti,
display an enhanced ability to survive the infection as compared to wild-type mice,
correlated with a decreased Th1 inflammatory cytokine responses along with reduced
neuropathology. Thus, inflammatory responses mediated by immune modules such as by
TLR system and γδ T cells, play detrimental roles during murine NCC. In contrast, despite
a reduced inflammatory response characterized by a decreased Th1 inflammatory
responses observed in the CNS of TLR2-/- NCC mice, these mice displayed a higher
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neuropathology correlated with an increased mortality. Interestingly, TLR2 -/- NCC mice
exhibited decreased numbers of M2 macrophages in the CNS, suggesting that maybe M2macrophages play an important protective role in mice i.c. infected with M. corti. Indeed,
after M. corti i.c. infection mice deficient in STAT6, which is a central regulator of M2
macrophage development and function (4), display a greater neuropathology and mortality
correlated with a scarce presence of M2 macrophages in the CNS. Thus, the M2
macrophages mediated protective mediators could be important for controlling the
neuropathology and overall disease severity in murine NCC.
Macrophages functional phenotypes in infections and injury
Macrophages are key effectors cells of the immune system (47). Macrophage
plasticity is essential for innate immunity and tissue remodeling (47-49). The functional
phenotypes of macrophage vary in response to external stimuli they receive through a wide
variety of surface receptors (50). Macrophage with the M1, or classical activation
phenotype, release multiple pro-inflammatory molecules (51). M1 or classically activated
macrophages are activated by environmental signals such as IFN-γ or TLR ligands. IFN-γ
binds to IFNGR-1 and IFNGR-2 chains which form INFGR-1 and recruit JAK1 and JAK2
adaptors proteins. Ultimately the activation of the signal transduction pathways involving
phosphorylation of STAT1, IRF-1, and IRF-8, ultimately orchestrate the transcription of
pro-inflammatory molecules (47). M1- macrophage activation associated production of
inflammatory molecules, including the production of NOS2, IL6 and TNF-α, play critical
role in protection from microbial pathogenic infection (47). In contrast, M2 macrophages
or alternatively activated macrophages are involved in anti-inflammatory and tissue
protective response (1, 49, 52-54). M2 macrophage activation results from exposure to
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environmental cues such as cytokines IL-4 or IL-13 (M2a subtype), agonists of IL-1
receptor and TLR (M2b subtype), IL-10 and glucocorticoid hormones (M2c subtype), or
activation of adenosine A2A receptors (M2d subtype) (17). The M2a macrophages are
involved in allergies responses induced by th2 responses and killing of parasites (1, 47).
The M2b phenotypes are involved in Th2 cells differentiation and humoral antibody
production. The M2c macrophages play a role in immune regulation and tissues repair (1,
47). Whereas M2d macrophages believed to play a role in protecting from tissue injury (1).
Thus, M2 macrophages are involved in many physiologic and pathological processes such
as homeostasis, inflammation, metabolic function, allergy, and parasites infection.
M2 Macrophages Functions in Wood Healing
Wood macrophages are referred IL-4 induced macrophages due to the several
tissues remodeling molecules produced by these macrophages including Arginase, and
YM-1 (48). Arginase-1 an enzyme is a prototypic marker of AAM in mice. For a long time,
Arginase-1 was believed to be the primary wound healing protein and it is induced
transcriptionally by TGF-β, IL-4, and IL-13 proteins. Arginase-1 uses the amino acid Larginine as substrate and break it down into L-ornithine and urea. L- Ornithine is believed
to be involved in collagen biosynthesis which ultimately promotes fibrosis and tissue
healing (55). YM-1 is a lectin with affinity to glycosaminoglycans like heparin. YM-1 is
considered as M2 marker in a mouse model and it is upregulated by IL4 and IL-13 and its
expression may be directly correlated IL-10 production. This protein has been associated
with cellular recruitment and extracellular matrix deposition during tissue repair.
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M2 Macrophages Functions in Helminth Infections
Immune response involving M2 macrophages are hallmarks of chronic type 2 pathological
conditions, including in helminth parasitic infection (3, 56). Specifically, M2 macrophages
have been suggested to involve in the expulsion of certain helminths (57). In this regard,
M2 associated molecule YM-1, a chitinase, play an important role in cleaving the surface
chitin on helminth parasites thereby making their plasma membrane accessible to host
mediators. Importantly, M2 macrophages functions in wound healing (4, 43, 47, 58)
thought to be crucial to repair tissues damages caused by the parasites or due to
inflammation (47, 57).
As mentioned before, M. corti infection of the CNS of mice resulted in massive
accumulation of M2 macrophages, correlated with a complete lack of any iNOS+ M1
macrophages (4, 43). As STAT6-/- mice infected with M. corti displayed a decreased
number of M2 macrophages correlated with severe disease sign (4), an understanding of
the molecular mechanisms associated with the development, recruitment, and/ or functions
of M2 macrophages in murine NCC could be important for understanding how NCC can
be clinically controlled.
Glycan antigens in host-parasite immune responses during NCC
More than 95% of NCC patients exhibit humoral responses against glycan antigens (13,
24). Glycan antigens are released both in humans and mice NCC (9, 29) and are taken up
by infiltrating immune cells around the metacestodes (9), suggesting their role in
immunopathogenesis. It is commonly believed that in order establish a long-lasting
infection in the host, parasites helminths release glycans present on their surface or through
excretory /secretory products (59, 60). These helminth parasite-derived glycans are
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grouped into two distinct sets: the host like and non-host like glycans (59). Various types
of host-like glycans are found in different parasites (61-63). The terminal glycan structures
shared by bost host parasites include LeX, LDN, and LDNF as well as the truncatedglycans known as the T (Galβ-3GaNAcα-O-Thr/Ser) and Tn (GalNAcα-O-Thr/Ser)
antigens (61-63). Remarkably, the host-like glycans can also induce the production of antiglycan responses resulting from the “foreign” presentation of the host-like glycan antigens
in highly multivalent forms as well as their linkage to immunogenic helminth proteins.
Interestingly, the synthesis of the non-host-like glycan moieties in the helminths appears
to be strongly upregulated during infection of the mammalian host (59, 64). In contrast,
non-host-like glycans contain unusual molecules including polyfucose, tyvelose, terminal
GalNAc, phosphorylcholine, methyl groups, and sugars with unusual linkages (59). As can
be expected, these non-host-like glycans are highly immunogenic in nature and induce the
generation of dominant anti-glycan antibody responses in infected hosts (62). Interestingly,
the synthesis of the nonhost-like glycan moieties in the helminths appears to be strongly
upregulated during infection of the mammalian host (64) suggesting a biological relevance
for their expression.
NCC patients exhibit humoral responses against N-glycan antigens, presumably
released from the parasite in the CNS. Indeed, carbohydrate-based antigens are extensively
used for immunodiagnosis of this disease. These glycan antigens are mostly expressed in
the parasite’s tegument (external surface) that remains in contact with the host as well as
secreted molecules. Both in human and mouse NCC, the glycans in tegument of T. solium
and M. corti are released into the CNS microenvironment (9). In murine NCC, the glycan
antigens containing terminal galactose and galactosamine is rapidly released (1-2d p.i.),
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whereas glycan antigens containing terminal glucosamines are constantly released during
the CNS parasitic infection. We speculate that interaction of some of these parasite glycan
antigens with PRRs e.g. lectin receptors dictate the immune regulatory mechanisms
involved in NCC (9, 41).
Lectin Receptors, Galectins: Structure, and Functions
PRRs (Patterns recognizing Receptors) are accountable to detect the presence
pathogens by recognizing their PAMPs (Pathogen Associated Molecule patterns) (25).
PRRs are expressed by host cells mostly by APC (antigen presenting Cells) which include
macrophages and dendritic cells but also by non-phagocytic cells. PRRs include the TollLike Receptors (TLRs), (RIG) - like receptors, the NOD-like receptors and the Lectin
receptors (LRs) (65, 66).
Lectin Receptors
Lectin receptors (LR) are carbohydrates binding proteins found in most animals
and plants (66, 67). Within multicellular organisms, protein–carbohydrate recognition is
critical to intracellular processes, such as protein folding and transport (66, 67). Such
interactions play various important homeostatic and protective functions in the hosts such
as extracellular matrix in its function including cell differentiation, adhesion, and
migration, and embryogenesis. Moreover, host lectins can also act like PRRs to sense
pathogen released molecules (66). Thus, LRs represent a family of multifunctional host
molecules that are involved in fine-tuning the host immune system in a variety of
conditions. Owing to such flexibility of these LRs in modulating a variety of immune
functions, it is necessary to study these and similar molecules in a microenvironment
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specific manner. However, the role of targeted LRs in the regulation of immune functions
during CNS helminth infection is limited, if any.
Galectins: Galectins are β- galactoside binding proteins which share the same
carbohydrate recognition domain (CRD) (68, 69). Based on their structural features,
mammalian Galectins had been classified into three different groups (26, 70). The prototypes galectins have one CRD per subunit and most of the time are associate as noncovalently bound homodimers through a hydrophobic interphase (26, 70). This group
includes galectins 1, 2, 5, 7, 10, 11,12,13,14, and 15. The chimera-type galectins have Cterminal a CRD similar to the proto-type. In addition, they possess an N-terminal aminoterminal peptide that is rich in glycine, tyrosine, and proline which is involved in the
formation of oligomers. The only member of that group is galectin 3. The last group is the
tandem repeat (TR) galectins. They have two CRDs joined by a linker peptide. The
members of this group include galectins 4, 6, 8, 9, and 12 (26, 70, 71).
Most galectins are non-glycosylated soluble proteins and are ubiquitously
expressed and distributed in mammalian tissues, including innate cells such as dendritic
cells, macrophages, mast cells, natural killer cells, γδ T cells, B1 cells and adaptive cells
such as activated B and T cells of the immune system (26, 70). Although they lack signal
sequence, they can be found in the extracellular, intracellular or nuclear milieu where they
perform different functions which include cell migration, cell and protein interaction, and
immune response regulation (26, 70). Their different functions are accomplished either by
protein-protein interactions of protein-glycan interaction (69). Galectins have increase
affinity to soluble extracellular matrix (ECM) glycoproteins such as fibronectins, lamins,
and vitronectin (26, 68-75). For instance, Lysosome-associated membrane glycoprotein 1
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(LAMP-1) is recognized by both galectin 3 and 1 (69). Moreover, galectin 3 binds to CD98
on macrophages and CD66 on neutrophils. Galectin 9 on the other hand has been known
to interact with Tim 3 and CD44 on activated T cells (26, 69, 76, 77). These galectins –
glycoproteins complexes can interact with other ECM proteins and lead to their regulation
effects and signaling cascades (26, 69, 76, 77). In addition, galectins also bind to
membrane-bound proteins. Their interactions modulate the immune responses and
inflammation (26, 69, 76, 77). Even though the role of galectins has been intensively
studied in tumors cells, recently, an increased attention has been given to explore their roles
during chronic infections.
Galectin 3, Immune Response, and the CNS: galectin 3 is unique in chimera group
and has been extensively studied for the past few years. It may have pro-inflammatory or
anti-inflammatory function depending on the pathogens as wells as it microenvironment.
Studies had shown galectin 3 intervenes in multiples cellular processes in vitro. It has been
shown to play a role in DC-T cells interaction as well as cell- matrix glycoprotein adhesion.
Galectin 3 exerts chemotactic effects, control cells proliferation (78). Furthermore,
extracellular galectin 3 promotes neutrophil functions such as survival, phagocytosis, and
extravasation (78, 79).
The role of galectin 3 during inflammatory conditions in the CNS had been
investigated. Even though galectin 3 is expressed at a low level by some brain cells
including neurons astrocytes and microglia, its expression is increased during some CNS
infection. Galectin 3 was considered as a pro-inflammatory molecule during murine EAE.
Despite its involvement in the phagocytosis of myelin debris in CNS which is advantageous
for neural regeneration, galectin 3 is also known to be involved in the aggravation of the
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of EAE because it plays a critical role in preventing apoptosis, reduce the production of
IL-10 and increase IL-17’s level (6). In addition, galectin 3 was proving to play a role in
mediating injury-induced microglia activation and proliferation in response to Ischemic
injury (80).
Galectin 3 and Helminth Infections: Galectin 3 expressed by DCs has been shown
to modulate immune and inflammatory response by controlling the magnitude of Tlymphocyte priming during helminthic infection (78). In addition, galectin 3 was found to
be indispensable for the recognition and endocytosis of yeasts and is essential for TLR2dependent cytokine production in response to C. albicans (81). However, its role
modulating innate responses during NCC is yet to be determined.
Galectin 3 and phagocytosis and efferocytosis. Studies had explored the role played
by galectin 3 during both phagocytosis and efferocytosis. Galectin 3 expressed on
macrophages was found to be critical in their phagocytosis function (5, 6). However, a
recent study had suggested that galectin 3 expressed on neutrophil may help with their
clearance during acute infection (82). Moreover, galectin 3 has been proven to not only
enhance alveolar Macrophages' differentiation into AAMs phenotypes, it also enhances the
clearance of apoptotic cells, therefore improves COPD (65). This suggested that galectin 3
may play a role in the function of AAMs during NCC infection.
Galectin 7 and Immune Response: Most of the studies done on galectin 7 had been in
cancers tumors. Galectin 7 is normally expressed by keratinocytes and restricted to
stratified epithelia, nevertheless, its expression is considerably altered in tumors cells (83).
It had been reported to up-regulate the growth and propagation of lymphoma cells in vivo
(84) as well as helping to eliminate tumors cells with it pro-apoptotic function (84). It
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typically non-cancerous infections, galectin 7 expression on epithelial cells was found to
be associated with pro-apoptotic functions as well as cell-cell adhesion (26, 70, 85).
However, the role of galectin 7 during helminth infections is yet to be determined.
Galectin 9 and Immune Response: Galectin 9 is another member of the galectins
family which has an increase of interest and it’s from the tandem repeat group. Studies had
shown galectin 9-Tim-3 interaction pathway induces antibacterial activity in human
macrophages which were infected with Mycobacterium tuberculosis (8). In addition,
galectin 9 was shown to be highly expressed by iTreg cells and its interaction with its
receptor CD44 increase iTregs cells stability and their functions (86). However, the specific
role of galectin 9 in the innate immune response during parasitic infection, particularly
NCC is yet to be determined.
Central Hypothesis
It has been assumed that viable cysticerci induce immune suppressive effects to evade the
immune response. Whereas after the degeneration of larvae caused by either therapeutic
treatment or normal attrition, the loss of parasite-mediated immune modulatory effects
leads to uncontrolled hyper-inflammatory responses contributing to tissue pathology. In
this regard, a considerable body of evidence indicates that the host inflammatory responses
elicited in the CNS contributes to nervous tissue pathology and is responsible for most of
the clinical symptoms observed with NCC patients. Thus, anti-inflammatory treatments
with corticosteroids are often prescribed along with anti-parasitic drugs to kill the organism
and control the host inflammatory response and neuropathology. However, long-term
treatments with steroids lead to life-threatening side effects. Therefore, it is important to
identify the pathophysiological basis of the inflammatory as well regulatory responses
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elicited in parasite-infected brains to aid in developing safer therapeutic strategies.
Although, we previously contributed in identifying the role of TLR signaling pathway in
regulating CNS inflammatory response and pathology, but the presence of the myeloid
cells with M2 activation phenotype seemed to be necessary for containment of tissue
pathology and disease severity. In this regard, one of the most important similarities
between human and murine NCC is the documented release of parasite glycans in the CNS
microenvironment. In addition, the terminal galactose-containing glycan are first to be
released from the parasite and to larger extent, which coincides with the presence of large
numbers of myeloid cells with M2 activation phenotype in the parasite-infected CNS.
Thus, our goal was to study the role of lectin receptors in regulating M2 cell functions in
the parasite-infected CNS. We hypothesize that the differential expression of galectins that
recognize galactose moieties, in endothelial cells play a critical role in immunopathology
by modulating trafficking of M2 macrophages into the CNS, whereas galectins expressed
in M2 cells controls the protective functions of these cell types.

1. Characterization of the differential expression and distribution of galectins in
endothelial cells and M2 cells during murine NCC.
2. Determine the function of galectin/s expressed in M2 cells, in regulating their
protective functions in CNS immunopathogenesis of murine NCC
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Figure I- 2. Galectins are upregulated during NCC.
WT mice were intracranially infected with M. corti. At 2 weeks post infected, brains
were isolated and galectins mRNA were measured. Galectins were found to be up
regulated at mRNA level.
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Abstract
Macrophages/ microglia with M2- activation phenotype are thought to play an
important anti-inflammatory and tissue reparative functions in the brain, yet the molecular
basis of their functions in the central nervous system (CNS) remain to be clearly defined.
In a preclinical model of neurocysticercosis using brain infection with a parasite
Mesocestoides corti, we previously reported the presence of large numbers of M2 cells in
the CNS. Here we report that M2 macrophages in the parasite-infected brain display
abundant galectin-3 expression. Disease severity was increased in Galectin 3-/- mice
correlating with increased neurological defects, augmented cell death and, importantly,
massive accumulation of neutrophils and M2 macrophages in the CNS of these mice.
Because neutrophil clearance by efferocytosis is an important function of M2
macrophages, we investigated a possible role of galectin 3 in this process. Indeed, Galectin
3 deficient M2 macrophages exhibited a defect in efferocytic clearance of neutrophils invitro. Furthermore, adoptive transfer of M2 macrophages from Galectin 3 sufficient WT
mice reduced neutrophilia in the CNS and ameliorated disease severity in parasite-infected
Galectin 3-/- mice. Together, these results demonstrate for the first time a novel role of
galectin 3 in M2 macrophage function in neutrophil turnover and resolution of
inflammatory pathology in the CNS. This likely will have implications in
neurocysticercosis and neuroinflammatory diseases.

Key words: M2 Macrophage, Galectin 3, CNS, brain, neurocysticercosis, neutrophil
turnover, neuroinflammation
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INTRODUCTION
Inflammation in the central nervous system (CNS) is often associated with
catastrophic neurological disabilities (87). A major component of this inflammatory
process is a robust innate immune response by microglia and their counterparts, the
peripherally derived macrophages that infiltrate into the brain during pathological insult
(31, 88, 89). Indeed, microglia/macrophages are potent modulators of CNS
repair/regeneration in several neuropathological conditions, including brain infections,
stroke, traumatic brain injury, and spinal cord injury (1, 90).
Macrophages and microglia respond to environmental cues by adopting polarized
functional phenotypes between activated M1-pro-inflammatory or M2-anti-inflammatory
and wound healing/ tissue reparative phenotypes (49, 50, 54, 91, 92). In this regard,
exposure to environmental factors such as pathogen-associated molecular patterns
(PAMPs) or host molecules such as IFN-γ and TNF-α, leads to activation of STAT1 and
NF-kB signaling cascades culminating in M1-inflammatory molecules production (51, 53,
57). These M1 inflammatory effector cells generally promote the destruction of pathogens
but cause widespread tissue damage when unchecked (93). On the other hand, M2
macrophage/ microglia activation results from exposure to environmental cues such as
cytokines IL-4 or IL-13 (M2a subtype), agonists of IL-1 receptor and TLR (M2b subtype),
IL-10 and glucocorticoid hormones (M2c subtype), or activation of adenosine A2A
receptors (M2d subtype recently identified in macrophages, but not in microglia) (94). In
general, the M2 cells dampen excessive host inflammatory responses and promote tissue
repair, including in the CNS (95, 96). Emerging evidence suggests that M2 cells are
involved in clearance of cellular debris by phagocytosis and release tissue
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protective/trophic factors (97, 98). Although functions of M2 subpopulations are not well
characterized in neuropathological conditions, M2 cells promote these restorative
processes in nervous tissue such as axonal remodeling and remyelination,
oligodendrogenesis and neurogenesis (99). In contrast, M1-macrophage/microglia are
found to impair these CNS repair process (90). These insights, although informative, have
primarily been derived from in vitro studies or in vivo by selective depletion of these cells
using chemicals. Direct mechanistic evidence showing the protective function of M2macrophages/ microglia in the CNS microenvironment thus, is lacking.
M2-macrophage associated response is a signature of helminth infections.
Therefore, experimental models involving helminth infections in the CNS can be important
to identify critical molecules and mechanisms in M2- macrophage/ microglia functions to
control brain pathology. In this regard, neurocysticercosis (NCC) is a common central
nervous system (CNS) parasitic disease caused by the presence of Taenia solium larvae in
the CNS (14, 100). The degree of immunological responses in CNS microenvironment
plays a critical role in the pathogenesis of this disease (12, 17, 101). A mouse model for
NCC, in which mice are intra-cranially (i.c.) inoculated with a related helminth
Mesocestoides corti (M. corti), has been used to systematically characterize various aspects
of the immune responses in the CNS microenvironment (17, 30, 43). Indeed, an absence
of M2 activation phenotype in macrophages/ microglia in the brain of parasite-infected
mice, as shown by us, causes severe neurological manifestations and mortality (4, 13)
Although the factors regulating M2-microglia/macrophages functions in murine NCC
brains are not completely understood, of particular importance are glycan antigens
containing terminal galactose and galactosamine that are released from the parasite in the
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CNS (17). These glycans released in the CNS microenvironment during murine as well as
in human neurocysticercosis interact with the infiltrating macrophages (9, 102), suggesting
a possible role for the host lectin receptors in M2- cell associated functions in the CNS, a
highly understudied area.
Galectins are host lectins that can recognize pathogen- or host-derived β-galactosides (74,
75). They interact with carbohydrates through conserved carbohydrate-recognition
domains (CRDs) and contribute to homeostatic as well as immune modulatory functions
in several pathological conditions (103). Galectins are broadly divided into three groups:
those containing one CRD (Galectin-1, 2, 5, 7, 10, 11, 13, 14 and 15); those containing two
distinct CRDs (galectin-4, 6, 8, 9 and 12); and galectin-3 (73, 104). Galectin 3 is a unique
member of the galectin family of molecules characterized by the presence of unusual
tandem repeats of proline- and glycine-rich regions. Although there is evidence for the
importance of galectin 3 to influence M2 macrophages development and trafficking (105),
virtually nothing is known about its role in M2-macrophage/microglia functional
phenotype in chronic CNS pathological conditions.
The goal of this study was to identify the expression and distribution of Galectin 3
in M2-macrophage and microglia in murine model of NCC. We compared the
susceptibility and immunopathology, including the dynamics of leukocytes infiltration in
the CNS, between the Galectin 3-/- and WT NCC mice. As galectin-3 was primarily
detected in infiltrating M2-macrophages, M2-macrophages from WT mice (Galectin 3
sufficient) were adoptive transferred into the Galectin 3-/- NCC mice to analyze resolution
of the CNS inflammation and disease severity. Based on our results from these studies, we
report a protective role of M2-macrophage specific galectin 3 in mitigating CNS pathology
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and disease severity, by regulating efferocytosis mediated neutrophil turnover during brain
parasitic infection. To our knowledge, this is the first report showing a protective function
of M2-macrophages critically regulated by galectin 3 in the CNS, in a neuropathological
condition.

Materials and Methods
Mice and Parasite Inoculation
Female mice age 4-6 weeks were used in this study. Galectin 3-/- mice on C57BL/6
were purchased from Jackson Laboratories (Bar Harbor, ME). C57BL/6 mice were
obtained from Charles River Laboratories (Wilmington, MA) and used as wild-type (WT)
controls. Both WT and Galectin 3-/- mice were bred in the animal facility of the University
of North Dakota. The animals were used according to institutional and federal guidelines
Murine model of neurocysticercosis
M. corti metacestodes used in this study were maintained in the peritoneal cavity
of BALB/c mice by serial intra-peritoneal (i.p.) inoculation as described by us before (40,
42). Mouse model of neurocysticercosis was developed as described by us (93, 106).
Briefly, anesthetized 4-6 wk old mice were intracranially (i.c.) injected with 50 μl of HBSS
containing about 40 parasites (103, 104). Mock control mice were i.c. injected with 50 μl
sterile HBSS using the same protocol. Death was recorded as infection-induced mortality.
Mice displaying severe signs of distress (non-responsiveness to cage tapping) were
humanely sacrificed and also recorded as infection-induced mortality. To analyze various
immunopathological parameters at indicated times post-inoculation, mice were

28

anesthetized with 100 µl of the above mixture, perfused through the left ventricle with 10
ml cold PBS, before the brains were aseptically collected.
Parasite burden, Histopathological and Immunofluorescence analysis
From the perfused control and parasite-infected mice, the brains were quickly
dissected out, embedded in O.C.T. (optimal cutting temperature), and snap frozen. Serial
horizontal cryosections of 10μm in thickness were placed on silane prep slides (SigmaAldrich, St. Louis MO). The slides were air-dried overnight and fixed in fresh acetone for
10s at room temperature (RT). Acetone-fixed sections were processed immediately for
hematoxylin and eosin (H&E) or were wrapped in aluminum foil and stored at -80°C to
perform immunofluorescence (IF) staining in future.
For H&E staining, after fixation in 4% formalin for 10 min at room temperature,
slides were washed twice in deionized water, dehydrated for 30s in 100% ethanol, stained
30s in hematoxylin, and washed in distilled water for 2 min (40, 42). Tissue sections were
stained with eosin for 15s followed by 2 min treatment with 95 and 100% ethanol each.
Slides were allowed to air dry, then submerged in xylene for 3 min, and mounted using
cytoseal mounting medium (Stephens Scientific, Riverdale, NJ). The number and location
of parasites were determined by microscopic examination of the stained tissues. Tissues
were also analyzed for the presence or absence of infiltrating leukocytes.
For IF microscopy, the frozen brain tissue sections were stained with relevant
antibodies to detect immune parameters such as galectin 3, and immune cells (107).
Briefly, brain tissue sections were incubated with specific primary antibodies in staining
buffer (PBS buffer with 3% host serum) to prevent non-specific binding. After 45 min of
incubations, sections were washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6 with
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0.1% Tween-20 and incubated with appropriate secondary antibodies in staining buffer for
30 min. Sections were then washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6
with 0.1% Tween-20. For double IF staining, the above-mentioned procedures were
sequentially repeated for each additional staining. The sections were mounted using
FluorSave reagent (Calbiochem, La Jolla, CA) containing 0.3 μM 4’, 6’-diamidino-2phenylindole (DAPI)-diacetate (Molecular Probes). Additional control staining was
performed to rule out any nonspecific staining. In each case, sections were blocked with
saturating concentrations of appropriate host serum antibodies to eliminate false positive
staining due to FcR-mediated nonspecific binding. Staining in the absence of primary
antibodies provided additional negative controls. Primary and secondary antibodies used
for IF staining are: Rabbit anti-galectin 3 (Abcam, San Diego, CA) and Alexa Fluor® 546
or Alexa Fluor® 488 goat anti-rabbit (Molecular Probes, OR), Rat anti-mouse 7/4
(Cedarlane, Burlington, NC) and Alexa Fluor® 546 or Alexa Fluor® 488 Goat anti-rat
(Molecular Probes, OR), Goat anti-mouse MGL1/2 (R&D system, Minneapolis, MN) and
Alexa Fluor® 546 or Alexa Fluor® 488 Donkey anti-goat Alexa 488/Alexa546 (Molecular
Probes, OR). We evaluated tissue damage on frozen brain tissue sections from control and
parasite-infected brains by performing the terminal deoxyribonucleotidyl transferasemediated triphosphate (dUTP)-biotin nick end labeling (TUNEL) staining as per
manufacturer's instructions (Chemicon International, CA). In all the cases, the images were
acquired using a Nikon eclipse 80i upright microscope (Nikon Corporation, Tokyo, Japan)
with an attached cooled RTke Spot 7.3 three spot color camera (Diagnostic Instruments
Inc., Sterling Heights, MI). The images were processed and analyzed using Adobe
Photoshop 7.0 software (Adobe, Mountain View, CA).
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Brain mononuclear cells isolation and flow cytometric analysis
Leukocytes from mouse brains were isolated as described by (108). In order to
prepare single cells suspension, each perfused brain was gently minced using Dounce
homogenizer in 3 ml of HBSS (w/o Ca2+, Mg2+) containing HEPES (10mM) (Invitrogen,
CA). The mixture was suspended in 30% percoll and then slowly overlaid on 70% percoll
(GE Healthcare, CA), centrifuged at 500 x g for 30 min at RT. The interface was collected,
pelleted at 200 x g for 5 min and re-suspended in HBSS, washed three times in 1 ml of
HBSS with 0.1% BSA (Sigma-Aldrich), and quantified by trypan blue staining before
performing flow cytometric analysis. Following antibodies were used for flow cytometry:
FITC anti-mouse CD11b (clone M1/70), PE-Cy7 anti-mouse F4/80 (clone BM8), PE antimouse TCR γδ (clone GL-3), PE-Cy7 anti-mouse Siglec F (clone FC50-2440), APC antimouse CD206 (clone C068C2), PE anti-mouse PD-L2 (clone T425), Pacific blue antimouse CD45 ( clone 30-F11) and APC anti-mouse Ly6G (Clone 1A8) antibodies (All from
Biolegend, San Diego, CA), and PE-anti-mouse galectin 3 (clone eBioM3/38) from
eBioscience.
Flow cytometric analyses for cell surface expression of relevant molecules were
performed on a BD LSR II flow cytometer (BD Biosciences) as we have previously
described (28). For intracellular galectin 3 staining in macrophages/ microglia, cells were
rinsed, stained for relevant surface markers at 4°C. Cells were fixed and permeabilized
using fixation and permeabilization buffer (eBiosciences) before intracellular galectin 3
was detected by staining in intracellular FACS buffer (eBiosciences) containing PE antimouse galectin 3 (eBiosciences) and analyzed on a BD LSRII flow cytometer.
RNA Isolation and Quantitative Real-Time PCR (qRT-PCR) analysis
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The qRT-PCR analysis was performed as described by us (34, 109). Total RNA
from mock control and parasite-infected brains were isolated using Trizol reagent
following manufacturers' instructions (Invitrogen) and as described by us before (40, 108).
One microgram of total RNA from each sample was reverse transcribed into cDNA by
using a high capacity cDNA reverse transcription kit according to the manufacturers'
instructions (Applied Biosystems, CA, and the USA). Transcript levels of galectin 3 or the
housekeeping ribosomal 18 S RNA were analyzed by RT-PCR using specific primers: 18S
(forward)

5'-CATGTGGTGTTGAGGAAAGCA-3'

5'GTCGTGGGTTCTGCATGATG-3',

galectin
and

CAGTGCAGAGGCGTCGGGAAA-3′

and
3

(reverse)

(forward)
(reverse)

5′5′-

CTGCCCCAGCAGGCTGGTTT-3′. Expression levels of galectin 3 were normalized to
the mRNA level of the housekeeping 18 S RNA gene in the same sample. The fold change
was calculated by dividing the normalized value of galectin 3 in parasite-infected brain
samples with the corresponding normalized value in mock-infected brain samples.
Macrophage Adoptive Transfer
For adoptive transfer of M1 or M2 macrophages in vivo, bone marrow cells were
isolated from WT mice and differentiated to macrophages as previously described (34,
110). Bone marrow-derived naïve macrophages on day 6 of differentiation were exposed
to IFNγ (20ng/ml, Peprotech) or to IL-4 (20ng/ml) to generate the M1-inflammatory or
M2-antiinflammatory phenotype respectively in vitro (92, 111). M1 macrophages were
labeled with Cell-tracker orange CMTMR (Life technologies) and M2 macrophages were
labeled with Carboxyfluorescein succinimidyl ester (CFSE cell proliferation kit Life
technologies) CellTracker at 37°C for 15 min as described by us before (112). 5x106
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labeled cells were then injected intravenously via tail vein (112) into WT and Galectin 3-/mice i.c. infected with M. corti for 6d prior to transfer. As control, WT and Galectin 3-/mice undergoing NCC in same experimental set up were injected with vehicle only.
Twenty-four hours after transfer, brains were harvested and processed for various
immunopathological analysis on parameters described in results section by following
above mentioned experimental protocols.
Ex-vivo Efferocytosis
For these studies, peritoneal neutrophils were isolated from WT mice 12-16hr after
intraperitoneal injection of sterile 4% thioglycollate (BD Biosciences, San Jose, CA) (46).
For macrophages, WT and Galectin 3-/- mice were injected i.p. with 4% thioglycollate on
day-0. On day-0 and day-2 mice were injected i.p. IL-4c mixture containing 5 µg of
recombinant murine IL-4 (Peprotech) and 25 µg of anti-IL-4 mAB (11b11, BioXcell),
whereas control animals received the vehicle, PBS. On day-4 peritoneal exudate cells
(PECs) were harvested and macrophages were analyzed for expression of M1/ M2
mediators by flow cytometry and RT-PCR before they were used for efferocytosis analysis
ex vivo. To compare efferocytosis by M2 macrophages induced by parasite infection, WT
and Galectin 3-/- mice were infected i.p. with M. corti (60-100 in numbers) and PECs were
harvested after 4-5wk p.i. to collect M2 cells. Mock control mice instead received vehicle
(PBS). On day-4 PECs were harvested to purify naïve macrophages for their role in this
process. To obtain neutrophils, WT mice were injected i.p. with 4% thioglycollate for 1618 hours.
The purity of the cells was ascertained by flow cytometry analysis (Ly6G+
neutrophils 80-85%; F4/80+ macrophages 85-90%). Isolated neutrophils were labeled with
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Carboxyfluorescein succinimidyl ester (CFSE; Cell Trace™ CFSE Cell Proliferation Kit
from Invitrogen). Macrophages seeded on 6 well plates (1x106 cell/ml) were incubated
with CFSE-labeled neutrophils at a ratio of 5:1(neutrophils: macrophages). After 2 hrs of
efferocytosis, non-internalized neutrophils were removed by washing thoroughly.
Macrophages were scraped and stained with F4/80 and Ly6G antibodies for flow
cytometry. Gating scheme to quantitate Ly6G-F4/80+ CFSE+ efferocytic macrophages
that had internalized labeled neutrophils is shown in Figure.II-8. For individual
experiments, efferocytic index was calculated as percentage of Ly6G-F4/80+CFSE+
macrophages from WT and Galectin 3-/- mice that engulfed neutrophils (112).
Statistical Analysis
The survival of the infected WT and Galectin 3-/- mice was compared using Logrank (Mantel-Cox) Test. The statistical comparison between levels of host mediators was
done with Student’s t test using Sigma Plot 8.0
H&E and Immunofluorescence Staining
Parasite and HBSS infected brains were immediately removed from perfused WT
and Galectin 3-/- mice, embedded in OCT resin and snap frozen. Serial horizontal cryosections with 10um in thickness were positioned on silane prep slides (from Sigma-Aldrich,
St. Louis, MO). Every 5th slides were sectioned and stain following the H&E staining
protocol previously described
Quantitative Real-time PCR
Brain from infected and mock control mice 1 WK and 3 WKS post infection were
directly perfused and the total RNA was extracted using trizol reagent (Invitrogen)
according to the manufacturer’s instructions. Real-time PCR analysis of the samples was
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done using SYBRO green (Applied Biosystems, CA (USA). Transcript levels of the
housekeeping ribosomal 18S ,Galectin 9 gene Galectin 3 genes were measured in each
sample by PCR amplification using specific primers: removed 18S (forward) 5'CATGTGGTGTTGAGGAAAGCA-3' and (reverse) 5'GTCGTGGGTTCTGCATGATG3'; Galectin 9 (forward) 5'- TCAAGGTGATGGTGAACAAGAAA-3’ and (reverse) 5’GATGGTGTCCACGAGGTGGTA

-3’;Gal3

5′CAGTGCAGAGGCGTCGGGAAA-3′

Galectin
and

3

(sense)
(anti-sense)

5′CTGCCCCAGCAGGCTGGTTT-3′
Statistical Analysis
The survival of the infected WT and Galectin 3-/- mice was compared using Logrank (Mantel-Cox) Test. The statistical comparison between levels of host mediators was
done with student’s test using Sigma Plot 8.0.
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Results
Galectin 3 is abundantly expressed in M2 macrophage recruited into the CNS
during murine NCC
To examine the role of galectin 3 in parasite-infected brains, its transcript-level of
expression was determined by qRT-PCR using RNA from mock and M. corti i.c. infected
brains. Increased mRNA expression of galectin 3 was observed at both 1wk and 3wk p.i.
over mock control (~ 27-fold increase at 1wk p.i. and ~14-fold increase at 3wk p.i)
(Figure.II-1A). To identify the cell-specific expression of galectin 3 protein, in-situ coimmunostaining was performed on brain cryosections of mock control and parasiteinfected mice. In mock-infected mice brains, galectin 3 was scarcely detected (Figure.II1B). In contrast, parasite-infected brains exhibit abundant galectin 3 protein expression at
both 1wk and 3wk p.i. (Figure.II-1B & C). Double IF staining on the parasite-infected brain
sections showed an accumulation of large numbers of round monocyte/ macrophage-like
CD11b+ or F4/80+ cells in meninges and ventricles that displayed positive staining for
galectin 3 (Figure.II- 1C). We have previously reported that the infiltrating macrophage in
the CNS of mice undergoing NCC display M2-, but not M1- activation phenotype (40, 42,
43, 58). Indeed, the MGL1/2+ infiltrating macrophages were stained positive for galectin
3 (Figure.II- 1D), suggesting that the M2- macrophages accumulating in the CNS during
parasite infection abundantly express galectin 3. In addition, some microglia cells as
determined by CD11b+ staining combined with typical cell morphology and brain
anatomical location exhibited galectin 3 expression (data not shown). Galectin 3 protein
expression was largely undetected in other nervous tissue or immune cell types e.g. CD11c
(dendritic cells), ᾳβT cells, γδT cells, neutrophils (7/4), B-cells (CD19) (data not shown).
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To further characterize the cell-specific expression of galectin 3 in infiltrating
macrophage and/ or microglia as well as to identify its cellular localization, the flowcytometric analysis was performed. It is important to note that CD45hiF4/80+ cells in the
CNS are known to be infiltrating macrophages, whereas CD45intF4/80+ cells represent as
microglia. Consistent with IF microscopy analysis, galectin 3 was primarily detected in
CD45hiF4/80+ macrophages in the CNS at both 1wk and 3wk p.i. (Figure.II-2B & 2C). In
contrast, only 7% of CD45intF4/80+ that are presumably microglia, displayed galectin 3
positive staining (Figure.II-2B & 2C). Interestingly, the majority of the CD45hiF4/80+
cells exhibited intracellular staining of galectin 3 (Figure.II-2B & C). In both 1wk and 3wk
p.i. mice brains, 80–90% of the CD45hiF4/80+ cells were MGL1/2+ or PD-L2+ (data not
shown), indicating that the galectin 3 expression is largely localized to the M2
macrophages in the CNS of M. corti i.c. infected mice undergoing NCC.
Galectin 3-/- mice exhibit increased disease severity during murine NCC
In light of abundant expression of galectin 3 in M2 macrophages, we sought to
examine the role of galectin 3 in overall disease severity during parasite infection of the
brain. For this, the development of neurological signs and survival of WT and Galectin 3/-

was compared. Neurological signs related to i.c. M. corti infection including abnormal

vestibular function, tilted head, and cerebral abnormalities were observed between 2-3wk
p.i. in WT mice. However, infected Galectin 3-/- mice displayed these signs much earlier
and were more accentuated between 2-3wk p.i. Importantly, M. corti-infected Galectin 3-/mice exhibited decreased survival as compared to the WT (Figure.II- 3A). At 3wk p.i., only
40% (4 of 10) of the M. corti i.c. infected Galectin 3-/- survived the CNS infection as
opposed to 100% (9 of 9) of the WT mice (Figure.II- 3A, p<0.005). Together these data
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suggest a protective role of galectin 3 in the pathogenesis of CNS parasite infection,
possibly relating to its expression in the infiltrating M2 macrophages in the CNS.
Galectin 3-/- mice exhibit no defect in parasite clearance or their segregation
Microscopic analysis of the H&E stained serial brain cryosections was performed
to determine the clearance of parasites and/ or their extravasation into specific CNS areas
in the absence of galectin 3. No statistically significant difference in the parasite loads was
observed in the CNS of WT and Galectin 3-/- NCC mice at 1wk and 3wk p.i. (Figure.II3B). Moreover, brain parenchyma or extra-parenchyma of WT and Galectin 3-/- mice at
1wk and 3wk p.i. exhibited no statistically significant difference in parasite count
(Figure.II-3B), although the Galectin 3-/- mice tended to exhibit a relatively lower number
of organisms in extra-parenchymal regions (Figure.II- 3B2). Thus, the protective function
of galectin 3 did not appear to relate to parasite clearance and/ or their segregation to
specific CNS sites of infected mice.
Galectin 3-/- mice exhibit severe neuropathology
We evaluated the gross CNS immunopathological changes in mock and i.c. M.
corti-infected WT and Galectin 3-/- mice. H&E stained brain cryosections of the control
animals of both strains that were i.c. inoculated with HBSS, displayed similar normal brain
tissue morphology with scarce presence of immune cells (Figure.II- 3C). In the parasiteinfected WT mice brains, presence of mixed leukocyte subsets were detected. A majority
of these infiltrating cells appeared to be monocyte/ macrophages at both 1wk and 3wk p.i.
(Figure.II- 3C, inset). In contrast, infected Galectin 3-/- mice brains appeared to exhibit an
increased CNS inflammation with transiently higher numbers of infiltrating immune cells
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compared to WT mice. In addition to the high numbers of immune cells with morphology
consistent with monocytes/ macrophages, polymorphonuclear cells (PMNs) were
abundantly detected between 2-3wk p.i. in Galectin 3-/- mice compared to their WT
counterparts (Figure.II- 3C, insert, shown at 3wk p.i.). To examine the impact of Galectin3 deficiency on the tissue pathology, TUNEL staining was performed on the brain tissue
sections of WT and Galectin 3-/- mice. Very little to no TUNEL positive cells were detected
in the CNS of mock and at 1wk p.i. in WT and Galectin 3-/- mice (data not shown). At 3wk
p.i. the TUNEL staining remained low in the WT brains, which was in contrast to the
Galectin 3-/- brains that displayed increased TUNEL detected staining at that time p.i.
(Figure.II- 3D). Interestingly, this increased TUNEL staining was detected in immune cells
present in the extra-parenchymal regions and surrounding nervous tissue cells in the CNS
of Galectin 3-/- mice. These data suggest that absence of galectin 3 dependent responses
leads to greater CNS inflammatory pathology during NCC.
To further examine the impact of galectin 3 deficiency on inflammatory response,
levels of multiple inflammatory cytokines and chemokines in brain homogenates were
compared between WT and Galectin 3-/- mice i.c. inoculated with HBSS or M. corti.
(Figure.II- 4). CBA analysis for key inflammatory molecules TNF-ᾳ, IL-1β, and IL-12p70
showed low basal levels of these cytokines in WT and Galectin 3-/- mice brains (Figure.II4). In contrast, M. corti-infected WT and Galectin 3-/- mice brains exhibited increased
levels of these mediators at 1wk and 3wk p.i., albeit there were no statistically significant
differences in IL-1β, and IL-12p70 levels between infected Galectin 3-/- and WT mice
(Figure.II- 4). TNF-ᾳ was detected at a lower level in Galectin 3-/- mice at 3wk p.i.,
compared to the WT counterparts (Figure.II- 4). On the other hand, significantly higher
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levels of neutrophil chemo-attractants (CXCL1, CXCL2), and monocyte/ macrophage
chemo-attractants (CCL2, CCL4) were detected in the brain homogenates of parasiteinoculated Galectin 3-/- mice at 1wk p.i. compared to the WT. Intriguingly, no significant
differences in the levels of these chemokines were detected in the CNS of Galectin 3-/- mice
at 3wk p.i. (Figure.II- 4), a time of peak disease severity displayed by them. Our results
suggest a possibility of higher accumulation of PMNs together with increased cell death in
the CNS to be likely the cause of enhanced disease severity observed in Galectin 3-/- mice
after brain parasite infection.
Galectin 3-/- mice display increased neutrophil and M2 macrophage accumulation in
the CNS after parasite infection
Majority of the immune cells recruited to the brain after parasite infection are
macrophages (2-3d p.i.), γδ T cells (3-5 days p.i), dendritic cells (1wk p.i.), ᾳβ T cells (1wk
p.i) and B-cells (3wk p.i.) (40, 42, 43, 58). In the M. corti infected brains, macrophages are
the most predominant leukocyte populations, whereas neutrophils are detected in relatively
in low numbers throughout the infection process (27). Within this context, H & E analysis
of the brain cryosections of M. corti parasite infected Galectin 3-/- mice appeared to display
a massive increase in numbers of infiltrating cells with morphology consistent with
neutrophils (Figure.II-3C). To determine whether a deficiency of galectin 3 alters
neutrophil numbers in the CNS, the expression of neutrophil marker 7/4 was analyzed by
in situ IF microscopy. In mock-infected brains of both WT and Galectin 3-/- mice, 7/4+
cells were scarcely detected (Figure.II- 5A). In the WT brain at 1wk p.i. little change in the
numbers of 7/4+ cells was detected as compared to the mock control mice, which increased
by 3 wk p.i.. Galectin 3-/- brains, on the other hand, exhibited a massive increase in 7/4+
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cells at 3wk p.i. as compared to WT mice (Figure.II- 5A). This suggested that absence of
galectin 3 cause increased of neutrophils accumulation in the infected brain.
Next, flow cytometry analysis was performed to enumerate immune cells
infiltrating the CNS of Galectin 3-/- and WT infected mice. Mononuclear cells from the
whole brain were isolated at an early stage of infection (1wk p.i.) and at the peak of
inflammation (3wk p.i.) (Figure.II- 5 and Figure.II- 6). The numbers of neutrophils in the
CNS of Galectin 3-/- and WT infected mice were determined by quantifying
Ly6G+CD11b+ cells. Consistent with the results from IF microscopy analysis, we found
no significant differences in the percent as well as absolute numbers of CD11b+Ly6G+
neutrophils in the CNS of parasite-infected Galectin 3-/- mice compared to the WT at 1wk
p.i. (Figure.II-5B). However, at 3wk p.i. the numbers of Ly6G+CD11b+ neutrophils were
significantly increased in the CNS of parasite-infected Galectin 3-/- mice as compared to
the WT mice (Figure.II-5B), confirming that galectin 3 deficiency leads to increased
accumulation of neutrophils in the CNS microenvironment during chronic infection. We
found no significant differences in the numbers of dendritic cells (CD11c+), γδ T cells
(TCRδ+), αβ T cells (TCRβ+) or B cells (CD19+) at 1wk or 3wk p.i. CNS of Galectin 3-/and WT mice (data not shown). To determine if the infiltration of M2 macrophages is
affected in the absence of galectin 3, the numbers of MR1+ or PD-L2+ was enumerated as
we previously have shown MR1 is upregulated on M2 macrophages in parasite-infected
brains whereas PD-L2 is a well-known marker of M2 cells (29, 43). Indeed,
CD45hiF4/80+MR1+, as well as CD45hiF4/80+PD-L2+ M2 macrophages, were detected at
both higher percentage and numbers in the CNS of infected Galectin 3-/- mice at 1wk and
3 wk p.i. as compared to their WT counterparts (Figure.II- 6A& 6B). This increased
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accumulation of M2-macrophages in the CNS of parasite-infected Galectin 3-/- mice was
statistically significant. Together our data suggested that galectin 3 in M2 macrophages
likely plays a role in containment of neutrophilia in the CNS.
Adoptive transfer of M2-macrophage from WT mice reduces neutrophilia in the
CNS and improves disease severity in recipient Galectin 3-/- mice during brain
parasitic infection
Galectin 3 was found to be expressed primarily in infiltrating M2 macrophage in the
CNS of M. corti i.c. infected mice. Because Galectin 3-/- NCC mice exhibited neutrophilia
and severe disease signs, we sought to examine if the adoptive transfer of galectin 3
sufficient M2-macrophages improves the disease severity. The effect on neutrophil
turnover in the CNS and disease severity was compared WT and Galectin 3-/- mice after
adoptive transfer of WT M2 macrophages. In initial experiments, macrophages were
isolated from the brains of i.c. infected WT mice to use as donor cells. However, even
though macrophages are the most predominant immune infiltrating cells found in the
parasite-infected WT mouse brains, it was difficult to isolate sufficient numbers of these
cells from the brain to perform adoptive transfer experiments in different groups. Thus,
naïve bone marrow-derived macrophages were polarization to the M2- phenotype using
well-characterized stimulus IL-4 for adoptive transfer experiments. M2- phenotype of
these cells was verified by analyzing M2-markers Arginase-1 and CCL24, but not NOS2
expression in these cells (data not shown). The M. corti i.c. infected WT and Galectin 3-/NCC mice received vehicle or WT-M2 cells i.v. at 1wk, and 2wk p.i. followed by analysis
of neutrophils numbers in the CNS of recipients. Flow cytometry analysis revealed that the
i.v. injected WT-M2 cells migrated into the CNS microenvironment of the recipient
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Galectin 3-/- or WT mice with similar relative efficiency (Supplementary Figure II. S1).
Indeed, more than 50% of the CFSE labeled WT-M2 cells (F4/80+CFSE+) injected i.v.
migrated into the CNS of the infected recipient mice at 24-h post adoptive transfer (Figure.
S1). In-situ IF microscopy with anti-7/4 was performed on brain cryosections from
recipient mice at 3wk of NCC to detect the accumulation of neutrophils. Transfer of WTM2 (experimental Group: WT NCC-WT M2) or vehicle (experimental Group: WT NCCVehicle) into the i.c. infected WT mice caused no apparent change in the number of 7/4+
neutrophils accumulated in the CNS (Figure.II- 7B). On the other hand, infected Galectin
3-/- mice i.v. injected with vehicle (experimental Group: Galectin 3-/-NCC-Vehicle) at 1wk,
and 2wks p.i., revealed the abundant presence of 7/4+ neutrophils in the CNS which was
substantially more compared to the experimental Group: WT NCC-WT M2 (Figure.II- 7B).
Importantly, transfer of WT M2 cells into i.c. infected Galectin 3-/- mice (experimental
Group: Galectin 3-/-NCC- WT M2) resulted in a significant decrease in the number of 7/4+
neutrophils accumulated in the CNS as compared to the Galectin 3-/-NCC mice that
received vehicle only (Figure.II- 7B). These results confirmed that Galectin 3 expressing
M2-macrophages regulate neutrophilia in the CNS during brain parasitic infection.
To determine whether adoptive transfer of galectin 3 sufficient WT-M2 cells would
prevent disease severity in Galectin 3-/- NCC mice, WT and Galectin 3-/- mice inoculated
i.c. with M. corti were i.v. injected with vehicle or WT M2 cells at 1wk, and 2wks p.i. as
discussed above. WT NCC-Vehicle displayed typical neurological signs (abnormal
vestibular function, tilted head, and cerebral abnormalities) by 3wk p.i.. These infection
induced disease signs appeared earlier and were more pronounced in Galectin 3-/-NCCvehicle group of mice. In addition, these Galectin 3-/-NCC that received vehicle exhibited
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decreased survival (Figure.II-7D). By 26 days p.i, % of M. corti-infected WT mice Galectin
3 was found to be expressed primarily in infiltrating M2 macrophage in the CNS of M.
corti i.c. infected mice. Because Galectin 3-/- NCC mice exhibited neutrophilia and severe
disease signs, we sought to examine if adoptive transfer of galectin 3 sufficient M2macrophages improves the disease severity. The effect on neutrophil turnover in the CNS
and disease severity was compared WT and Galectin 3-/- mice after adoptive transfer of
WT M2 macrophages. In initial experiments, macrophages were isolated from the brains
of i.c. infected WT mice to use as donor cells. However, even though macrophages are the
most predominant immune infiltrating cells found in the parasite-infected WT mouse
brains, it was difficult to isolate sufficient numbers of these cells from the brain to perform
adoptive transfer experiments infected Galectin 3-/- mice (experimental Group: Galectin 3/-

NCC- WT M2) resulted in a significant decrease in the number of 7/4+ neutrophils

accumulated in the CNS as compared to the Galectin 3-/- NCC mice that received vehicle
only (Figure.II-7B). These results confirmed that galectin 3 expressing M2-macrophages
regulate neutrophilia in the CNS during brain parasitic infection. By 26 days p.i, %25 of
M. corti-infected WT mice succumbed to the infection as compared to 80% of Galectin 3/-

mice (4of 5) (Figure.II- 1, p<0.005). In contrast, none of the Galectin 3-/-NCC-WT M2

mice exhibited severe neurological signs during the 3wk p.i. and all survived the infection.
This data strongly showed that adoptive transfer of Galectin 3-sufficient M2-MФ
ameliorated disease severity and improved survival during CNS parasite infection in
Galectin 3-/- mice.

44

Galectin 3-/- M2-MФ exhibit impaired efferocytosis of neutrophils
A prominent anti-inflammatory and tissue reparative function of M2-macrophages
is efferocytic clearance of infiltrating immune cells (97, 98, 113, 114). In order to gain
mechanistic insights into the role of Galectin 3 expressed in M2-MФ in regulating
neutrophil accumulation in helminth-infected brains, we compared ex-vivo efferocytosis
of CFSE- labeled neutrophils by M2-macrophages from WT and Galectin 3-/- mice by flowcytometry (Figure.II-8). For this, Galectin 3-/- and WT peritoneal M2-macrophages isolated
from the M. corti i.p. infected (Figure.II-8B) or thioglycollate + IL-4 complex i.p. injected
mice (Figure.II-8C) were incubated with CFSE labeled neutrophils. M2-phenotype of
macrophages was ensured by flow cytometry analysis of differential expression of M1/M2
markers PD-L2, MR-1, ARG-1, and NOS2, as described above. As shown in (Figure.II8B and 8B’), after 3 hrs of incubation, efferocytic uptake of CFSE-labelled neutrophils was
significantly less in Galectin 3-/- M-macrophages as compared to their WT counterparts.
Similar results were obtained with WT and Galectin 3-/- M2 macrophages differentiated
with peritoneal injection of IL-4 complex (Figure.II- 8C and 8C’). These data strongly
suggested that galectin 3 expression in M2-macrophages is required for efferocytic uptake
of neutrophils by these cells.
DISCUSSION:
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Increasing evidence from several experimental neuropathological models such as in
traumatic brain injury suggests that M2-macrophage are the first to infiltrate into CNS
tissues (97, 115). As the injury persists, a shift to increased accumulation of M1 phenotypic
macrophages in the CNS coincides with the inflammatory pathologic phase (94). Whereas
regulatory immune mediators such as IL-10, TGF-β have been implicated in M2 cells
mediated immune suppression/ anti-inflammatory response, important central regulatory
mechanisms involved in M2-macrophage functions to contain CNS inflammation and
pathology need to be identified. The data presented here show that during brain helminth
infection of the CNS, cytosolic galectin 3 is increased specifically in M2 macrophages, but
not substantially in microglia. Concomitantly, absence of galectin 3 resulted in a massive
increase in the accumulation of neutrophils correlating with heightened disease severity in
M. corti infected Galectin 3-/- mice as compared with WT mice. Galectin 3 deficiency in
M2-macrophages decreased efferocytic clearance of neutrophils by these cells.
Importantly, pathological sequelae, including severe neutrophilia in CNS parasite infected
Galectin 3-/- mice, were ameliorated by adoptive transfer of Galectin 3 sufficient M2
macrophages. Our study shows, for the first time, a protective role of M2-macrophage
associated galectin 3 in brain parasitic infection by controlling neutrophil turnover in the
CNS. There has been a growing appreciation for a role of macrophage/ microglia with M2
functional phenotype having a profound role in different aspects of CNS repair and
containment of immunopathology in the brain (90). Indeed, results from our previous
studies with STAT6-/- or TLR2-/- mice provide direct evidence for the critical protective
role of the myeloid cells with M2 functional phenotype in the brain microenvironment,
during CNS parasite infection (13, 43). Here we observed that the parasite-infected
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Galectin 3-/- mice, despite showing the presence of an increased number of M2macrophages in the CNS compared to their WT counterparts, exhibit severe neurological
signs and are highly susceptible to the infection. In the CNS of Galectin 3-/- mice, perhaps
the observed elevated amount of the chemokines including, CCL2 that are known to
involve in trafficking of monocytes/ macrophages (116, 117), facilitates the increased
influx of M2 cells. This indicated to us that the protective function, but not the
development, of M2-cells is dependent on galectin 3. Indeed, in the parasite-infected
brains, galectin 3 was primarily detected in infiltrating M2 macrophages and the transfer
of Galectin 3 sufficient M2 macrophage from WT mice reversed the infection-induced
CNS pathology and improved the survival of parasite-infected Galectin 3-/- mice. These
results highlight the importance of galectin 3 in M2 macrophages mediated protective
functions to contain CNS pathological process. However, it remains to be determined the
consequence as well as the mechanisms involved in the increased accumulation of M2macrophages in the CNS of parasite-infected Galectin 3-/- mice. In this regard, it has been
suggested that galectins, including galectin 3, can play a role in immune cell trafficking
(118-120). However, our results showed that adoptively transferred galectin 3 sufficient as
well as -deficient M2-macrophages accumulated in the CNS of both WT and Galectin 3-/mice with similar frequency. This strongly supports the idea that the enhanced disease
severity in Galectin 3-/- NCC mice was a direct consequence of a lack in the galectin 3
mediated response from M2 cells, but not due to a defect in M2 macrophage development
or trafficking (105, 120). In M. corti- infected WT mice brains neutrophils were detected
as a minor proportion of the immune cells present in the brain of M. corti- infected WT
mice. Earlier studies have also identified similar low numbers of neutrophils in the CNS
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microenvironment during murine NCC (30). However, infected brains in Galectin 3-/- mice
display a massive increase in the number of neutrophils as compared to the WT mice,
suggesting a role for galectin 3 in regulating neutrophil turnover. The transfer of M2macrophage from WT could reverse this increased of neutrophil accumulation in the CNS
microenvironment of M. corti –infected Galectin 3-/- mice, thus providing additional
support for a role of galectin 3 in M2 macrophage-mediated containment of neutrophilia.
This observation is exciting, as the absence of M2-macrophages has been shown to
associate with increased neutrophilia and reduced eosinophilia during infection with a
nematode parasite, Brugia malayi, but the mechanism remained unknown (3). Indeed, in
M. corti i.p. infected Galectin 3-/- mice, we observed a reduced eosinophilia coinciding with
the increased neutrophilia (data not shown) further supporting a fundamental role of M2
macrophage-associated functions of galectin 3 in controlling neutrophilia. Although the
molecular pathway of galectin 3 mediated containment of neutrophilia in the CNS
microenvironment remains to be determined, our data showing a defect in efferocytosis of
neutrophils by Galectin 3-/- M2 macrophages in vitro suggests its regulatory role in
efferocytic ability of these cells. In this context, a recent report has suggested that galectin
3 expressed and secreted by neutrophils auto-regulate their turnover during a self-resolving
model of peritonitis with zymosan injection (82). It has further been suggested that galectin
3 secreted by neutrophils facilitates efferocytosis of these cells by interacting with its ligand
on macrophage surface (65). However, the data from our studies clearly suggested a
cytosolic, but not extracellular presence of galectin 3 in M2 macrophages in parasiteinfected brains. Moreover, if secreted galectin 3 was involved in containing neutrophilia in
parasite-infected brain, we would expect to detect galectin 3 on the surface of macrophages
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and/ or neutrophils, which was not the case. Thus, galectin 3 in M2 macrophages regulates
neutrophil turnover by efferocytosis in the CNS microenvironment. The findings that
several signature inflammatory mediators are present at a similar level in the CNS Galectin
3-/- mice despite exhibiting low survival raised the fundamental question of whether M2
subsets are sufficient to contain NCC and other CNS pathological conditions. Indeed, in
human NCC patients the hyper-inflammatory responses in the CNS thought to contribute
to tissue pathology and mortality (121). Thus, along with anti-parasitic drugs, treatment of
NCC patients with immunosuppressive/anti-inflammatory factors such as corticosteroids
is frequently used to control the associated neuropathology, despite the life-threatening side
effects associated with long-term treatments with steroids (82). Within that context, we and
others have shown a decreased expression of the inflammatory mediators in M. corti
infected γδT-/- or MyD88-/- mice is associated with reduced pathology and longer survival
times. But, despite presence of lower brain levels of these inflammatory mediators, M. corti
infected TLR2-/- mice presented an increased CNS pathology and disease signs (13). We
have also shown that the reduced numbers of M2 macrophages observed in TLR2-/- mice,
and more importantly in the CNS of STAT6-/- mice, coincided with severe disease signs in
murine NCC (42). Thus, the findings from these studies that galectin 3 can profoundly
influence M2- macrophage cell functions in the CNS may be directly relevant to human
disease notably involving CNS pathological conditions.
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Figure II- 1. Expression and distribution of galectin 3 in the parasiteinfected brains.
Quantitative RT-PCR analysis and IF microscopy were performed on parasite-infected and mock
control mice i.c. injected with helminth parasite M. corti. (A) The total RNA was extracted from the
brains at 1wk and 3wk post inoculation and mRNA expression of galectin 3 was measured by qRTPCR as described in Methods. The fold changes in parasite-infected brains were calculated over the
levels in mock control mice using the formula 2−(ΔΔCt). Data shown are the mean ± SEM of 3–4 mice
per time point in two independent experiments. (B1& B2) Double immunofluorescence staining was
performed on brain tissue cryosections from mock or parasite- infected C57/BL6 mice. Nuclei (blue)
were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Galectin 3 was stained using an
affinity purified anti-mouse galectin 3 goat IgG followed by Alexa Fluor® 488 labeled (Green) goat
anti-rabbit IgG. (B3) galectin 3 expression was co-visualized with macrophages using an affinity
purified anti-mouse F4/80 Alexa Fluor® 488 labeled (Green) or (B4) MGL1/2+ cells using an
affinity purified anti-mouse MGL1/2 goat IgG followed by Alexa Fluor® 546 labeled (red) donkey
anti-goat IgG. Images shown are representative of 3 independent experiments with 3–4 mice each.
Magnification of 20X.
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Figure II- 2. Infiltrating M2 macrophages in the parasite-infected brains express
galectin 3 in the cytosol, but not on cell surface.
Mice were injected i.c. with HBSS (mock) or 60 helminth parasite (infected), and brain
mononuclear cells were isolated at 3wk post inoculation. (A) Gating scheme to select
C45hiF4/80+Galectin 3 positive cells. Collected cells with gated with FSC and SCC
Singlet cells. The cells were then gating on CD45 and F4/80 and galectin 3 positive cells.
(B) Representative FACS plots gated on CD45hi and F4/80+ (infiltrating macrophages) or
gated on CD45int and F4/80+ (microglia) cells from individual mouse brain showing
intracellular or cell surface expression of galectin 3. (C) Quantification of galectin 3
expression in CD45hiF4/80+ macrophages or CD45intF4/80+ microglia. Results are
representative of 3 independent experiments. **P <0.005 as determined by t test.
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Figure II- 3. Galectin 3-/- mice exhibit reduced survival and increased brain
pathology despite exhibiting similar parasite burden as the WT mice.
(A) WT and Galectin 3-/- mice were i.c. infected with 60 M. corti and were assessed daily
for disease severity. The survival was monitored for 3 weeks post inoculation. Statistical
comparison of susceptibility was done by Log-rank (Mantel-Cox) Test, p= 0.0047 **,
n=9-10. (B) Number of parasites at 1wk and 3wk p.i. in parenchymal (P) and extra
parenchymal (EP) regions in individual Galectin 3-/- and WT brains were calculated by
microscopic examination of serial H&E-stained brain sections. The bars show average +/SEM parasites from 5-6 mice per group. (C) Representative microscopic evaluation of
H&E stained brain cryosections from WT and Galectin 3-/- mice i.c. injected with HBSS
(mock) or with 40 parasites at indicated times p.i.. Magnification 200X. (D). IF
microscopy analysis was performed on brain cryosections from WT and Galectin 3-/mice i.c. infected with 60 M. corti parasites to detect TUNEL positive staining (Red).
Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Images
are representative of 5-6 mice in each group from three independent experiments.
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Figure II- 4. Inflammatory mediators in the CNS of parasite-infected Galectin 3-/and WT mice.
The brains from mock control and M. corti infected WT and Galectin 3−/− mice were
harvested at 1wk and 3wk i.c., homogenized, and the protein level of host immune
mediators measured by CBA using flow cytometric analysis (BD Biosciences). Results
shown are mean ± SEM of 3–4 each infected and mock control mice from 2–3
independent experiments. Statistical significances are denoted by asterisks (*, p<0.05; **,
p<0.005).
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Figure II- 1. Parasite-infected Galectin 3-/- mice exhibit increased neutrophil
accumulation in brain.
(A)IF microscopy on brain cryosections from WT and Galectin 3-/- mice i.c. injected with
HBSS (mock) or with 60 parasites at 1wk and 3wk i.c. Neutrophils (7/4+) were detected
by using an affinity purified anti-mouse 7/4 goat IgG followed by Alexa Fluor® 546
labeled (red). Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate
(DAPI). Images shown are representative of 3 independent experiments with 3–4 mice
each group.(B) Flow cytometry analysis of CD11b and Ly6G on brain mononuclear cells
harvested From mock control and M. corti infected WT and Galectin 3−/− mice at 1wk
and 3wk i.c. The cells were double-stained with anti-Ly6G-APC and anti-CD11b-Pacific
Blue Antibodies as markers for neutrophils. Representative contour plots show
CD11b+Ly6G+ neutrophils in brains of parasite-infected WT and Galectin 3−/− mice. The
bar graph on the right shows mean ± SEM of percent of CD11b+Ly6G+ neutrophils in
brains of M. corti infected WT and Galectin 3−/− mice each from 3 independent
experiments. Statistical significances are denoted by asterisks (* p<0.05).
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Figure II- 6. Parasite-infected Galectin 3-/- mice exhibit increased M2 macrophages
accumulation in brain
(A) Flow cytometry analysis of CD45, F4/80 and Mr-1 or (B) CD45, F4/80 and PD-L2
on brain mononuclear cells harvested from mock control and M. corti infected WT and
Galectin 3-/- mice at 1wk and 3wk i.c. The cells were with anti-CD45-Pacific Blue, antiF4/80-PE-cy7, anti-MR-1-APC and PD-L2-PE antibodies as markers for infiltrating M2
macrophages in brains of M. corti infected WT and Galectin 3-/- mice each from 3
independent experiments. Statistical significances are denoted by asterisks (* p<0.05, **
p<0.005)
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Figure II- 7. Galectin 3 expressing M2 macrophages exhibit protective role during
NCC infection.
(A)Schematic representation of the adoptive transfer experiment as described in the
Methods. Purified bone marrow macrophages from WT mice were differentiated to M2
phenotype by exposure to IL-4 in vitro. These M2-macrophages or vehicle alone were
injected i.v. into WT or Galectin 3-/- recipient mice at 1wk and 2wk of i.c. infection with
M. corti. Survival of mice, brain tissue pathology and neutrophil accumulation in the
CNS were compared to 3wk i.c. (B) Top panel shows representative images of H&E
stained brain cryosections. Bottom panel show IF microscopy images of brain
cryosections to compare accumulation of 7/4+ (green) neutrophils. (C) Bar graph
showing 7/4+ neutrophils manually counted from images shown in (B). (D) The survival
of NCC-WT or NCC-Galectin 3-/- mice adoptively transferred with WT-M2 macrophages
or vehicle was monitored for three weeks. Statistical significance was determined by
student t test (** p<0.005).
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Figure II- 8. Galectin 3-/- M2-macrophage exhibit reduced efferocytosis of
neutrophils ex-vivo
(A). Gating scheme to select efferocytic cells. singlet cells gated on FSC-H and FSC-A
and the Ly6G negative to eliminate untaken neutrophils that may be on the surface of
macrophages and CFSE positive to quantify the macrophages that internalized the
neutrophils (Ly6G-F4/80+ CFSE+ cells) (B). Efferocytosis of CFSE+ neutrophils by
macrophages from WT and Galectin 3-/- mock control mice that received vehicle (M0
PBS) or M. corti parasite (M2- M. corti) intraperitoneally. The bar graph (B’) indicates is
the percent of Ly6G-F4/80+CFSE+ macrophages that have internalized CFSE labeled
neutrophils calculated from 3 independent experiments that are shown in the
representative density plots (B). (C). Macrophages from WT and Galectin 3-/- mock
mice that received vehicle (M0-Mock) or IL4complex (M2- IL4c) by i.p. were analyzed
for efferocytosis of CFSE labeled neutrophils. The bar graph (C’) indicates is the percent
of Ly6G-F4/80+CFSE+ macrophages that have internalized CFSE labeled neutrophils
calculated from 3 independent experiments that are shown in the representative density
plots (C).
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Figure II- S1. Peritoneal macrophage from WT mice exhibit M2-activation
phenotype during M. corti i.p. infection.
Peritoneal macrophages from mock control and M. corti i.p. infected mice were
harvested, and the relative mRNA expression of M2 mediators, Arg1, PDL-2, MR-1, and
M1 inflammatory mediators, NOS2 was measured by qRT-PCR.
** p ≤ 0.01 and *** p ≤ 0.001 (Student's t-test).
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Figure S2. M2 macrophages extravasate into the CNS of WT and Galectin 3-/- mice at
similar rate
Purified bone marrow macrophages from WT mice differentiated to M2 activation by exposure to
IL-4 in vitro, labeled with Carboxyfluorescein succinimidyl ester (CFSE) CellTracker Green, i.v.
injected into WT or Galectin 3-/- recipient mice at 1wk i.c. infection with M. corti prior to injection.
Twenty four hour post adoptive transfer brains were harvested and processed for flow cytometry to
measure the accumulation of CFSE positive cells in the CNS.
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Abstract
M2 macrophages function to dampen host inflammatory responses and promote
wound healing and tissue repair. As the blood-brain barrier (BBB) restricts the flow of both
cells into the brain, understanding how M2 macrophages extravasate into the central
nervous system (CNS) is of great interest. In a mouse model of neurocysticercosis (NCC)
we previously demonstrated that M2 macrophages are essential in containing
neuropathology in helminth-infected CNS. Analysis of helminth-infected mice revealed an
abundant expression of Galectin 7 (Gal 7) that recognize galactose moieties in brain
endothelial cells. The Galectin 7-/- NCC mice displayed a reduced accumulation of M2
macrophage in the parasite-infected brain. This reduction in M2 macrophage numbers in
the CNS was correlated with an increased neuropathology and shortened survival. The use
of adoptive transfer of fluorescently labeled cells demonstrated a decreased influx of M2
macrophage into the CNS of helminth-infected NCC brains. The use of in-vitro
transmigration assay conclusively demonstrated a key function of Galectin 7 expressed on
endothelial cells in centrally regulating M2 macrophage entry into the CNS.
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INTRODUCTION
The central nervous systems (CNS) is regarded as an immunologically privileged
organ due to the absence of a classically defined lymphatic drainage system and the
presence of the blood-brain barrier (BBB) that restricts the influx of blood-borne molecules
and immune cells. However, when brain homeostasis is compromised as a result of
challenges such as during infection, injury, or trauma, innate immune activation can lead
to infiltration of various leukocytes to mount stimuli specific responses in the CNS
microenvironment (116). In this regard, microglia and infiltrating macrophages function as
the primary regulators of the innate immune-mediated development of inflammatory
responses in the CNS (122-125). The functional phenotypes of macrophage/ microglia vary
in response to external stimuli they receive through a wide variety of surface receptors (50).
These cells with the M1, or classical activation phenotype, release multiple proinflammatory molecules (51). M1-macrophages are critical effectors of inflammation and
innate immunity as well as orchestrators of adaptive immunity to microbial infections (126,
127). Whereas, macrophage/ microglia with M2, or alternatively activated phenotype,
produces factors involved in anti-inflammatory and tissue remodeling functions (49, 53,
54, 128). Interestingly, persistent M1 microglia/macrophages mediated pro-inflammatory
mediators often have tissue destructive effects eventuating into severe neuropathological
outcome in diseases affecting the CNS. In contrast, M2 phenotypes of these cells release
numerous protective/trophic factors in vitro settings (129, 130). Because of the presumed
ability of M2 cells to promote tissue repair/regeneration, transplantation of ex vivo
activated M2 macrophages was used in clinical trial as a possible cell-based regenerative
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strategy in spinal cord injury (131). Unfortunately, the phase II trial was not a complete
success, and necessitating the requirement of further understanding of different aspect of
M2 macrophage functions in the CNS. Use of pre-clinical models, where M2 macrophages
play an important contributor to the CNS immunopathogenesis, could be vital to identify
critical molecules responsible for their functions in brain.
The immune response during helminth parasitic infections predominantly involves
M2 macrophages (132). Indeed, in a murine model of neurocysticercosis, due to intracranial infection with a helminth Mesocestoides corti, the newly recruited macrophages
display an M2 phenotype (40, 43, 58). Importantly, a lack of the M2 phenotype in
macrophages was correlated with profound nervous tissue pathology and severe disease in
STAT6-/- NCC mice (42). Interestingly, the M2 macrophages influx coincided with the
release of glycan containing antigens from the tegument of the parasite in the CNS
microenvironment

(40).

Furthermore,

glycan

antigens

with

terminal

galactose/galactosamine are released from the parasite early and to larger extent. This
raised the possibility of these antigens may induce glycan (with-terminal galactose)recognizing receptors to shape M2 macrophages trafficking into the CNS and the overall
pathogenesis during brain parasitic infection. In this regard, the egress of leukocytes from
the blood into tissues is tightly regulated and is mediated by a multistep process involving;
leukocyte rolling, rapid activation of leukocyte, adhesion to endothelium, and diapedesis
(117, 133). The interaction of leukocytes to the endothelium and successful transmigration
involves different selectins that bind to specific carbohydrates, such as sialyl Lewis X
(sLeX) on the endothelium or vice versa (117). Furthermore, studies show that C-type
lectin receptors (CLRs) that bind to specific carbohydrates influence the outcome of
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leukocyte accumulation in tissues by positively or negatively influencing leukocyte
trafficking into the affected site (14). For example, CLRs such as MR1 and DC-SIGN have
been observed to mediate cell trafficking across endothelium (134-138) whereas MGL and
galectin 1 can inhibit migration of leukocytes through endothelium (137, 139). An
important unanswered question, therefore, is whether specific lectin receptor/s are induced
on brain endothelium during helminth infection to control M2 macrophage extravasation,
which in turn play an essential role in the containment of this disease.
In this study, we identified that intracranial infection of mice with M. corti
metacestodes results in upregulated expression of galectin 7 on brain endothelial cells. As
galectin 7 expression was also upregulated in brain-derived endothelial cells in vitro after
exposure to helminth factors or IL-4, the best-documented cytokines produced by the host
in helminth infection. The susceptibility and immunopathology was compared between
Galectin 7-/- and wild-type (WT) mice infected intra-cranially with M. corti. The
contribution of galectin 7 to CNS inflammation was assessed by measuring infiltration of
various immune cells into the brain, as well as pro-and anti-inflammatory mediators
response in CNS of Galectin 7-/- and WT mice. By studying Galectin 7-/- and WT mice in
vivo or brain-derived endothelial cells ex-vivo, for the first time, we demonstrate that
galectin 7 on brain endothelial cells regulate trafficking of M2 macrophage.
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Materials and Methods
Mice and parasite inoculation.
Female mice age 4.5 to 6 weeks were used in this study. The C57BL/6 WT mice
were purchased from Charles River Laboratories, Wilmington, MA. The Galectin 7-/- mice
were kindly provided to us by Francoise Portier (Universite Paris Diderot, France).
Mesocestoides corti (M. corti) was kindly provided by Dr. Debrosky Herbert (Cincinnati
Children’s Research Foundation, Cincinnati, OH 45229, USA). M. corti metacestodes
were maintained in the peritoneal cavity of BALB/c mice by serial intraperitoneal (i.P.)
infection for propagation.
For intracranial infections, M. corti larvae were aseptically collected from the
intraperitoneal cavity of the infected BALB/c mice and were extensively washed in HBSS.
The metacestodes (about 60 parasites) were suspended in 50 µl of sterile HBSS and
injected intracranially into 4.5 to 6 weeks old female mice using 1 ml syringes and a 25gauge needle. Control mice were given 50 µl of sterile HBSS. Priority to the inoculation,
the mice were anesthetized with a mixture of xyline (120 µl /ml), ketamine (220 µl /ml)
and PBS. 50 µl of the mixture was given to each mice.
At 1 week and 3 weeks, mice were anesthetized using isoflurane and perfused
through the left ventricle with 20 ml of cold PBS.
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Brain mononuclear cell isolation and Flow cytometry
The brain was instantly removed from perfused mice and leukocytes were
processed for antibodies staining for flow cytometry analysis. Briefly, leukocytes single
cells suspensions were isolated from parasite-infected brains of WT and Galectin 7-/using percoll density gradient from GE healthcare (CAT# 17-0891-01). The cells were
counted using trypan blue. 2x106 cells were pre-incubated with Fc blocker for 10min and
then incubated with 50 µl of antibodies cocktail for 30 min. after incubation, the cells
were washed 2 times with 500 µl FACS buffer (10% FBS in PBS) and the pellets were
suspended in 350 µl of FACS buffer and analyzed on a BD LSRII flow cytometer (BD
Biosciences).
H&E Staining.
Parasite and HBSS infected brains were immediately removed from perfused WT
and Galectin 7-/- mice, embedded in OCT resin and snap frozen. Serial horizontal cryosections with 10 µm in thickness were positioned on slides (from Sigma-Aldrich, St. Louis,
MO). Every 5th slides were sectioned and stain following the H&E staining protocol
previously described.
Adoptive transfer experiment
WT and Galectin 7-/- mice were intracranially infected with M. corti for 6 days.
They were then adoptively transferred with labeled BMDM which were previously
cultured with IL-4 (M2) or IFN-γ (M1). The M2 macrophages were labeled with cell trace
CFSE (CAT# C34554, Thermo scientific Waltham, MA) and the M1 was labeled with Cell
Trace Far-Red orange dye (CAT# C34564, Thermo scientific Waltham, MA).The cells
labeled cells were a mix at 1:1 ratio and intravenously injected to the infected mice. via tail
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vein injection. Brains were harvested 24 hrs after the tail vein injections, the infiltrating
cells were collected and processed for flow cytometry as described above. Adoptively
transferred macrophages recruited to the brains were enumerated using an LSR II flow
cytometer and analyzed using FlowJo software (BD Biosciences, San Jose, CA).
Endothelial cell’s isolation
Mouse brain endothelial cells were isolated like it was described (140) and with the
help of Dr. Abhay Sagare and Dr. Zlokovic V. Berislav with little modifications. Briefly,
Brains were aseptically isolated for 8 weeks of WT and Galectin 7-/- mice using the
MCDB31 medium (GIBCO BRL, New York) supplemented with 2% FBS, 100U/ml
penicillin, and 100 µl/ml streptomycin. Meninges and big vessels were removed. The
cortices were then cut into small pieces and homogenized using tissues Dounce
homogenizer. The mixture was suspended in 15% dextran and centrifuged. The pellet was
re-suspended in 0.1% collagenase/dispase made with 2% FBS medium. The mixture was
incubated for 6hr at 37oC with sporadic agitation. After the incubation, the mixture was
centrifuged at 1000Xg for 5 and the endothelial cells and microvessels found in the top
layer were collected, centrifuged and plated in tissues culture plate coated with rat tail
collagen I (Roche Diagnostics, Mannheim, Germany) and incubated at 37 with 5% C02.
Every 2 days, the media was changed to enhance recovery.
After few days of culture, the cells were collected using enzyme-free dissociation
buffer and a magnetic purification step was used to reduce contamination. Briefly, the cells
were incubated with rat CD31 primary antibody (1:50, BD Pharmagen, Lexington, KY)
for 30 min at 4oC with gentle mixing. After incubation, cells were centrifuged and
incubated with Dynabeads M-450 Sheep anti-rat for 20 min with shaking. The cells were
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then washed and collated using magnet and plate on collagen I coated plate for father
incubation. In addition, 70,000 cells were seeded in the insert with 8 µm pore (CAT#
Corning) with media in the low chamber of the transwell.
Trans-endothelial migration essay
Once the cells had grown to appropriate confluency in the insert, FITC labeled
dextran was used is a tie junction between the endothelial cells, 5µg/ml of dextran
(3000MW, CAT#D3305 Thermo Fischer Scientific) was diluted in PBS and added to the
endothelial cells. the concentration of dextran was measured in the low media using
colorimeter. The cells were stimulated with Parasite derived molecules for 12 hrs. The
lower media was changed with fresh media. Then the bone marrow-derived macrophages
that were previously cultured with IL-4 to induce M2 phenotype were added to the upper
chamber of the insert 5x105 macrophages were added with 500 µl of media. In order to
mediate migration of the macrophages to the lower chamber, macrophages MCP-1 at
100ng/ml was added to the media in the low chamber. After 24 hr of incubation, cells in
the low chamber were counted.
Immunofluorescence
Immunofluorescence microscopy was used to determine the presence of immune
mediators and/or specific cells types in brains of parasites infected and non-infected mice
at various times post-infection 1wk. Brains from mock (HBSS infected) mice were used as
controls and IF staining. All steps were carried out at room temperature. Briefly, the
sections were incubated 10% host serum for 30 min, then with specific antibodies in PBS
buffer with 3% host serum to prevent non-specific binding. After 40 min, the sections were
washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6 with 0.1% Tween-20 washing
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buffer. The sections were then incubated with appropriate secondary antibodies for 30 min
and were washed seven times with the above washing buffer. For double
immunofluorescence staining, the above-mentioned procedures were sequentially repeated
for each additional staining. The sections were mounted using Fluorsave reagent
(Calbiochem, La Jolla, CA) containing 0.3 μM 4’, 6’-diamidino-2-phenylindole (DAPI)diacetate (Molecular Probes). Additional control staining was performed to rule out any
nonspecific staining. In each case, sections were blocked with saturating concentrations of
appropriate host serum antibodies to eliminate false positive staining due to FcR-mediated
nonspecific binding. Staining in the absence of primary antibodies provided additional
negative controls.
In addition, IF microscopy in vitro settings using primary brain-derived endothelial
cells (isolation described above) and bEnd.3 [BEND3] (ATCC, USA), a brain capillary
endothelial cell line. Cells were pulsed with medium alone or exposed to helminth secreted/
soluble factors (HSF) or with IL-4. Bend.3 cells line ([Bend.3] (ATCCR CRL-2299TM).
with specific antibodies in PBS buffer with 3% host serum to prevent non-specific binding.
After 40 min, the sections were washed seven times 3 min each in 50 mM Tris-HCl, pH
7.6 with 0.1% Tween-20 washing buffer. The sections were then incubated with
appropriate secondary antibodies for 30 min and were washed seven times with the above
washing buffer. For double immunofluorescence staining, the above-mentioned procedures
were sequentially repeated for each additional staining.
Antibodies and reagents
All reagents were purchased from Sigma-Aldrich unless otherwise indicated. For
detection of Galectin 7 by immunofluorescence (IF) staining, a purified rat anti-mouse
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galectin 7 antibody clone 212923 (R&D system, Minneapolis, MN) followed by Alexa 546
conjugated goat anti-rabbit antibody (Molecular Probes, OR) was used. A rat anti-mouse
CD31 antibody conjugated to Alexa 488 (BD Pharmingen) were used for IF staining. A
purified goat anti-mouse MGL1/2 (CAT# AF4297, R&D system, Minneapolis, MN)
followed by donkey anti-goat Alexa 488/Alexa546 (Molecular Probes, OR). A purified
goat anti-mouse MR-1 (CAT# AF2535, R&D system, Minneapolis, MN) followed by
donkey anti-goat Alexa 488/Alexa546 (Molecular Probes, OR). For flow cytometry FITC
anti-mouse CD11b (clone M1/70), PE-cy7 anti-mouse F4/80 (clone BM8), PE anti-mouse
TCR γδ (clone GL-3), PE-cy7 anti-mouse siglec-f (clone FC50-2440), APC anti-mouse
CD206 (clone C068C2), PE anti-mouse PD-L2 (T425), pacific blue anti-mouse CD45
(clone 30-F11), and APC anti-mouse Ly6G (Clone 1A8) antibodies (Biolegend, San Diego,
CA) were used. The terminal deoxyribonucleotidyl transferase-mediated triphosphate
(dUTP)-biotin nick end labeling (TUNEL) staining kit was purchased from Chemicon
International, CA. The endotoxin level was <1.0 EU per μg of protein. Ultrapure E. coli
endotoxin was purchased from Invivogen and lactose was purchased from Sigma.
Quantitative Real-Time PCR
Brain from infected and mock control WT and Galectin 7-/- mice 1 week and 3
weeks post infection were directly perfused and the total RNA was extracted using trizol
reagent (Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis
of the samples was done using SYBRO green (Applied Biosystems, CA (USA). Transcript
levels of the housekeeping ribosomal 18S and Galectin 7 genes were measured in each
sample by PCR amplification using specific primers: 18S (sense) 5′- CAT GTG GTG TTG
AGG AAA GCA-3’ and (antisense) 5′- GTC GTG GGT TCT GCA TGA TG-3′; galectin
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7 (sense) 5’-GGC CAC TTT-GTT-GTA-TTG-3’ and ( antisense) 5’-GAC CAT GCC TCG
AAT TCT CAT-3’
Statistical Analysis
The survival of the infected WT and Galectin 7-/-mice was compared using Logrank (Mantel-Cox) Test. The statistical comparison between levels of host mediators was
done with student’s t-test using Sigma Plot 8.
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Results
Galectin 7 is abundantly expressed in brain endothelial cells during murine NCC
To examine the role of galectin 7 in parasite-infected brains, its transcript-level of
expression was determined by qRT-PCR using RNA from mock and M. corti i.c. infected
brains. Increased mRNA expression (by ~ 2.5-fold) of galectin 7 was observed at 1wk p.i.
over mock control at 1wk p.i. (Figure.III-1A). To identify the cell-specific expression of
galectin 7 protein, in-situ co-immunostaining was performed on brain cryosections of mock
control and parasite-infected mice. In mock-infected mice brains, galectin 7 was undetected
(Figure.III-1B1). In contrast, parasite-infected brains exhibit an increased expression of
galectin 7, which was primarily evident in periventricular and leptomeningeal areas of the
NCC brain (Figure.III-1B1-B2). A unique extracellular matrix (ECM)-like fibrillar
staining pattern for galectin 7 was observed (Figure.III-1B1-B2). Double IF staining on the
parasite-infected brain sections showed large numbers of round monocyte/ macrophagelike CD11B+ or F4/80+ cells extravasating through the pial vessels in meninges and
detected in proximity of galectin 7 (Figure.III-1B3).
The expression of galectin 7 on brain endothelial cells is unknown. To test the
physiological relevance during helminth infections, the specificity of galectin 7 expression
on brain endothelial cells was evaluated by IF microscopy in vitro settings using primary
brain-derived endothelial cells as well as bEnd.3 [BEND3], a brain capillary endothelial
cell line. Cells were pulsed with medium alone or exposed to helminth secreted/ soluble
factors (HSF) or with IL-4. In this regard, IL-4 has been shown to be the critical cytokine
72

shaping many of the host response to helminth infections, including the signature M2
phenotypic response by macrophage. Both bEnd.3 [BEND3], cells and primary brain
endothelial cells exposed to HSF exhibited increased galectin 7 expression (Figure. III1C). On the other hand, galectin 7 was undetected in the naïve/ unstimulated control cells
cultured in presence of medium only (Figure. III-1C). Moreover, galectin 7 expression at
protein level was detected at a massively higher level in IL-4 exposed bEND3 cells
compared to the corresponding unstimulated naïve/ control cells (figure.III-1C). Together,
the results confirmed that HSF and IL-4 stimulation induces an increased galectin 7
expression, specifically in endothelial cells (CD31+) in vitro.
Galectin 7-/- mice exhibit increased disease severity during murine NCC
To investigate whether Galectin 7 influences host immunity to parasite infection of
the brain, disease severity was compared between WT and Galectin 7-/- mice were infected
i.c. with M. corti. As reported previously (141, 142), infected WT mice displayed typical
neurological signs including abnormal vestibular function, tilted head, cerebral
abnormalities, morbidity, and weight loss between 1-3wk p.i. In general, these overt signs
appeared earlier and were more accentuated in Galectin 7-/- mice. In addition, Galectin 7-/mice exhibited decreased survival. By 5wk p.i., only ~10% % of M. corti-infected WT
mice succumbed to the infection as opposed to ~70% of Galectin 7-/- mice (Figure.III- 2A,
p<0.0005).
To determine the parasite burden, serial horizontal sections of parasite-infected WT
and Galectin 7-/- brains of mice were stained with H&E, evaluated by microscopic analysis.
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The brains of Galectin 7-/- mice exhibited increased numbers of parasites as compared to
the infected brains of WT mice (Figure.III- 2B). Additionally, an increased numbers of M.
corti was observed in brain parenchyma in Galectin 7-deficient mice, however, it was not
statistically significant (Figure.III- 2B). Together, the results suggest that in the absence of
galectin 7 dependent responses lead to an increased parasite growth in the CNS.
Next, H&E staining was performed to determine immunopathological changes in
WT and Galectin 7-/- mice (Figure.III- 2C). Both the WT and Galectin 7-/- mice displayed
normal brain tissue morphology. In contrast, a large number of infiltrating immune cells
was detected in the CNS of both WT and Galectin 7-/- (Figure.III- 2C), albeit a somewhat
lower number of infiltrating cells with morphology consistent with monocytes/
macrophages (round cells) was observed in the extra-parenchyma of parasite-infected
Galectin 7-/- mice as compared to the WT (Figure.III-. 2C).
To examine the impact of galectin 7 deficiency on the tissue pathology, TUNEL
staining was performed on the brain tissue sections of WT and Galectin 7-/- mice. Very
little to no TUNEL positive cells were detected in the CNS of mock of both WT and
Galectin 7-/- mice (data not shown). Although the TUNEL staining remained low in the
parasite-infected WT brains, the Galectin 7-/- mice displayed an increased TUNEL staining
in the CNS (Figure.III- 2C). These data suggest that absence of galectin7 dependent
responses leads to greater CNS inflammatory pathology during NCC.
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Galectin 7-/- mice display decreased M2 macrophage accumulation in the CNS after
parasite infection
To determine the physiological relevance of galectin 7 on the infiltration of immune
cells into the CNS during NCC, flow cytometry analysis was performed. Mononuclear cells
from the whole brain of Galectin 7-/- and WT infected mice at 1wk p.i. The percent of
macrophages (CD11b+F4/80+), neutrophils (CD11b+Ly6G+), eosinophils (Siglec-F+), γδ
T cells (TCRδ+), αβ T cells (TCRβ+) or B cells (CD19+) were measured. No significant
differences in the numbers of neutrophils, eosinophils, γδ T cells, αβ T cells or B cells at
1wk p.i. in the CNS of parasite-infected Galectin 7-/- compared to the WT mice (Figure.III3). However, infected Galectin 7-/- mice displayed significantly lower numbers of
infiltrating macrophages in the CNS at 1wk p.i. Thus, these data demonstrate that absence
of galectin 7 leads to a significant reduction in macrophage recruitment into the brain
during NCC.
Our previous studies have demonstrated that mice deficient in STAT6, an adaptor
molecule contribute to the development of M2 macrophage phenotype (4), exhibit a lack
of macrophages with M2 phenotype in the CNS correlated with increased pathological
signs and severe mortality in NCC. To determine the effect of galectin 7 deficiency on the
level of macrophages with M2 phenotype in the CNS during NCC, the expression of
MGL1/2 (a cell surface marker specific for M2 cells) was analyzed in Galectin 7-/- mice by
IF microscopy (Figure.III- 4A). Consistent with our previous findings, parasite-infected
WT mice displayed an accumulation of large numbers of macrophages (CD11b+ cells)
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with MGL1/2 (M2 activation phenotype) in the CNS at 1wk p.i. (Figure.III- 4A). In
contrast, the parasite-infected Galectin 7-/- mice exhibited reduced accumulation of
CD11b+MGL1/2+ M2 macrophages in the CNS (Figure.III- 4A). Taken together, the
results here suggested that deficiency of galectin 7 is associated with a reduced influx of
M2 macrophages in the CNS during NCC.
Next, to determine if the infiltration of M2 macrophages is affected in the absence
of galectin 7 flow-cytometric analysis was performed by staining the cells with anti-CD45,
anti-F4/80, and PD-L2. It is important to note that CD45hiF4/80+ cells in the CNS are
known to be infiltrating macrophages, whereas PD-L2 is a well-known marker of M2
activation phenotype in macrophages (29, 45). Indeed, CD45hiF4/80+PD-L2+ M2
macrophages were detected at significantly reduced numbers in the CNS of infected
Galectin 7-/- mice at 1wk p.i. as compared to their WT counterparts (Figure.III- 4B).
Together our data suggested that galectin 7 likely plays a role in the accumulation of M2
macrophages in the CNS.
Galectin 7 deficiency causes decreased M2 macrophages extravasation in vivo and in
vitro
In order to confirm the role of galectin 7 in M2 macrophage recruitment into the
CNS of NCC mice, we performed adoptive transfer of WT (Galectin 7+/+) M2- and M1macrophage into WT and Galectin 7-/- mice (Figure.III- 5A, B). For this, naïve bone
marrow-derived macrophages were polarized to M2- phenotype after exposure to IL-4,
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whereas cells were stimulated with IFN-γ to drive their polarization to M1-functional
phenotype (verified by expression of M1 activation marker NOS2) (data not shown). For
adoptive transfer experiments, M1 and M2 macrophages were labeled with two different
intracellular dyes (M1 cells with CFSE and M2 cells with CellTraceTM far-red dye).
Injecting a mix of M1- and M2- types of macrophages and in equal numbers allowed us to
compare the relative migration efficiency of these cells in the exact same
microenvironment. The M. corti i.c. infected WT and Galectin 7-/- mice at 1wk p.i. received
M1 or M2- macrophages by i.v. followed by flow cytometry analysis to measure CFSE+
cells and CellTraceTM+ cells after in the whole brain mononuclear cells. We observed that
M2 macrophages were recruited in lesser numbers in parasite-infected brains of recipient
Galectin 7-/- mice (Figure.III- 5B). However, no difference in the recruitment of M1macrophages was observed in recipient WT and Galectin 7-/- mice. (Figure.III-5B).
Notably, i.v. injected M1 cells migrated with a lower relative efficiency compared to the
M2 cells in the CNS microenvironment of the recipient parasite-infected WT and Galectin
7-/- or WT mice. This is likely due to a CNS microenvironment, which is conducive for M2
macrophage recruitment. Nonetheless, these results further solidified the fact that WT
(Galectin 7+/+) M2- macrophages, but not the M1 macrophages, infiltration into the brain
of Galectin 7-/- NCC mice is reduced. Next, transwell migration assay was performed to
measures the capacity of M2 macrophages to transmigrate across a monolayer of brainderived endothelial cells from WT and Galectin 7-/- mice. Brain endothelial cells were
isolated from both WT and Galectin 7-/- mice. Cells were cultured in a transwell insert to
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form a monolayer as described in methods and by Dr. Zlokovic group (140). Cells were
stimulated with helminth soluble/ secreted factors for 24h to induce galectin 7 expression.
Bone marrow-derived macrophages that were polarized to M2- phenotype (described
before), CFSE labeled, and 5x105 number of cells added to the upper chamber. The lower
chamber contained media with 100ng/ml of MCP-1 chemoattractant for macrophages.
Deficiency of galectin 7 on endothelial cells in upper chamber appear to affect M2macrophage trans-endothelial migration as evidenced by lower numbers of CFSE+ cells
accumulated in the corresponding lower chamber (Figure.III- 5C). Together, the findings
suggested a novel role of galectin 7 in specifically controlling M2 macrophages
extravasation through brain en Galectin 7-/- NCC mice display reduced M2-macrophage
associated anti-inflammatory/ immune mediators in the CNS

Galectin 7-/- mice display decreased M2- macrophage-associated antiinflammatory/ tissue protective mediators in the CNS after parasite infection
To determine a functional relevance of galectin 7 in the anti-inflammatory/ tissue
protective response in parasite-infected CNS microenvironment, levels of multiple immune
mediators e.g. cytokines, chemokines, and enzymes with tissue repair function, were
compared in brain homogenates by CBA analysis and/ or RT-PCR analysis (Figure.III- 6).
As compared to the mock animals the M. corti-infected WT and Galectin 7-/- mice brains
exhibited increased levels of several inflammatory molecules, including key factors e.g.
TNF-ᾳ, IL-1β, IL-12p70, IL-6, GM-CSF, IFN-γ, CXCL-9, -10, and NOS2, however there
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were no statistically significant differences in their levels observed between infected
Galectin 7-/- and WT mice (Figure.III- 6). On the other hand, significantly lower levels of
anti-inflammatory factors (IL-13, IL-9, and especially the IL-10) were detected in the brain
homogenates of parasite-inoculated Galectin 7-/- mice at 1wk p.i. compared to the WT.
Moreover, the significance of galectin 7 was further corroborated with the RT-PCR
analysis to measure the mRNA level of the factors directly involved in tissue regeneration/
repair such as YM1, Fizz1, and ARG-1. M. corti-infected brains of WT mice displayed a
massive upregulated expression of these molecules (25 to several hundred-fold) over those
in mock animals at both 1wk p.i. (Figure.III- 6B). In contrast, there was only a moderate
increase in the mRNA level of these anti-inflammatory/ tissue protective factors in the CNS
of parasite-infected Galectin 7-/- mice (Figure.III- 6B). Our results strongly suggest a
decreased anti-inflammatory/ tissue protective response in the CNS of Galectin 7-/- mice
after brain parasite infection.
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Discussion
Increasing evidence supports an important role for M1 and M2 phenotype-specific
roles of macrophages in multiple steps of CNS repair/regeneration (130). A switch from
M1 to M2- phenotypic macrophages/ microglia facilitate diverse protective functions such
as remyelination, oligodendrocyte renewal and white matter integrity, axonal regeneration,
promote neurogenesis in models of multiple sclerosis to CNS injuries (143-145). On the
other hand, a phenotype shift from M2-dominant to M1-dominant of macrophages at the
site of injury impairs CNS repair (146-150). As most of the macrophages are recruited from
the blood circulation to the CNS site in pathological settings, a better understanding of the
mechanism of trafficking of these cells to the CNS is needed. It is also critical to identify
how the macrophage trafficking regulator/s affect the anti-inflammatory/ tissue protective
effect of these cells once inside the brain. Together, these could lead to the identification
of novel therapeutic strategies to modulate macrophage function to promote CNS repair
and/ or contain CNS pathology. Here we report that galectin 7, a host lectin receptor is
upregulated specifically on the brain endothelial cells, and impacts the outcome of brain
helminth infection as evidenced by a reduced survival, enhanced CNS pathology, because
of decreased accumulation of M2- macrophages and associated immune mediators in the
CNS of Galectin 7-/- mice. The use of in vitro transmigration assay as well as in vivo
adoptive transfer experiments provided mechanistic basis of a key regulatory function of
galectin 7 on endothelial cells in centrally regulating M2 macrophage entry into the CNS.
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Our study shows, for the first time, a CNS protective role of galectin 7 by controlling M2
macrophage influx into the helminth-infected brain.

After the infection of the CNS by M. corti during murine NCC, both parasites and
immune cells are initially accumulated in extra parenchymal areas of the brain, which
include ventricles, meninges and subarachnoid spaces (10, 30, 32, 39, 40). As the infection
progresses, parasites and immune cells extravagate into the brain parenchyma typically
depending upon the duration of infection (10, 30, 32, 39, 40). Macrophages represent the
first type of immune cells to infiltrate into the brain (within first 3d p.i.) and are the
predominant leukocyte populations throughout the infection process (4, 30). It was recently
demonstrated that the initial release of galactose/ galactosamine containing glycan antigens
by 1-2d p.i. precedes the accumulation of infiltrating macrophages with M2 activation
phenotype. The early upregulated expression of galectin 7 on endothelial cells of the extraparenchymal CNS vasculature in the M. corti-infected WT brain, and in brain-derived
endothelial cells after activation with helminth soluble/ secreted factors or IL-4 in vitro,
suggest that galectin 7 may regulate the recruitment of immune cells into the brain. The
severe reduction in M2 macrophages accumulation in the CNS of M. corti-infected
Galectin 7-/- mice supports this idea. However, the early accumulation of all other immune
cells were unaffected in Galectin 7-/- mice compared to their WT counterparts, indicating
that Galectin 7 may be specifically involved in M2-macrophages influx only. Indeed, the
adoptive transfer of both M1 and M2-macrophages of the WT origin demonstrated that
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Galectin 7 was required only for the accumulation of M2-macrophages, but not M1macrophages, in the parasite-infected brains.
Our findings raised the fundamental question of whether the direct interaction
galectin 7 on brain endothelial cells have with M2 macrophage facilitates regulates the M2
cells trafficking. Alternatively, perhaps galectin 7 has an indirect role in this process by
functioning as a PRR, whose activation leads to the induction of chemokines modulating
M2 macrophages trafficking into the CNS. However, the expression of various key
macrophage recruiting chemokines were unaffected in the CNS of Galectin 7-deﬁcient
mice following parasite infection. In case galectin 7 functioning as a PRR, we would expect
to observe a decrease in macrophage chemoattractants in the CNS of Galectin 7-/- mice.
Furthermore, we would expect the adoptively transferred M1 and M2 macrophages to reach
the CNS of both WT and Galectin 7-/- NCC mice with similar frequency, which was not
the case. On the other hand, in vitro transmigration assay settings, the extravasation of M2macrophages, but not M1-macrophages, was impaired through the monolayer brainderived endothelial cell from Galectin 7-/- mice compared to their WT counter parts. These
results further highlight the likely critical function of the galectin 7 on brain endothelial
cells directly interacting with the M2 macrophages and mediating their transmigration into
the CNS during brain parasitic infection.
Galectin 7 deficiency resulted in increased parasite burden both in the extraparenchyma and parenchyma of the brain. It is likely that reduced numbers of M2
macrophages play a role in limiting parasite growth in the brain of Galectin 7-/- mice. This
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is consistent with the results from our previous studies (4, 10) in murine NCC as well as
from studies involving other parasite infections, a defect in Th2 dependent M2macrophages associated responses contribute to parasite growth correlated with increased
disease severity in the host (151-153). Although a direct role of Galectin 7- mediated M2macrophage accumulation and associated responses, contributing to disease severity was
not established in the present study, the enhanced disease severity of Galectin 7-/- NCC
mice was correlated with decreased IL-10 and IL-13 in the CNS as compared to WT mice.
This indirectly indicates a possible protective role of galectin 7 through influencing M2macrophages trafficking in NCC. We are currently performing relevant adoptive transfer
experiments to identify whether the transfer of WT M2 macrophages directly into the CNS
of Galectin 7-/- NCC mice by i.c. injection with WT M2-macrophages would ameliorate
the disease severity. The findings that galectin 7 on brain endothelial cells function as a
central regulator in M2-macrophages influx into the CNS, and in its absence the reduced
accumulation of M2 cells contribute to the lethality of Galectin 7-/- mice, may offer
important mechanisms to target in CNS inflammatory disease conditions.
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Figure III- 1. Expression and distribution of galectin 7 in the parasite-infected
brains and endothelial cells.
Quantitative RT-PCR analysis and IF microscopy were performed on parasite-infected and mock
control mice i.c. injected with helminth parasite M. corti and endothelial cells. (A) The total RNA
was extracted from the brains at 1wk post inoculation and mRNA expression of galectin 7 was
measured by qRT-PCR as described in Methods. The fold changes in parasite-infected brains were
calculated over the levels in mock control mice using the formula 2−(ΔΔCt). Data shown are the mean
± SEM of 3–4 mice per time point in two independent experiments. (B1-B2) Immunofluorescence
staining was performed on brain tissue cryosections from mock or parasite- infected C57/BL6 mice.
Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Galectin-7 was
stained using an affinity purified anti-mouse galectin 7 goat IgG followed by Alexa Fluor® 546
labeled (red) goat anti-rabbit IgG. (B3) Immunofluorescence staining was performed using purified
anti-mouse galectin 7 and purified anti-mouse CD11B followed by Alexa Fluor® 488 labeled
(Green). Images shown are representative of 3 independent experiments with 3–4 mice each.
Magnification of 20X. (C) Immunofluorescence staining was performed brain Bend3 endothelial
cells lines and primary endothelial cells pulsed with medium alone or exposed to helminth secreted/
soluble factors (HSF) or with IL-4. Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindoledilactate (DAPI). Galectin 7 was stained using an affinity purified anti-mouse galectin 7 rat IgG
followed by Alexa Fluor® 546 labeled (red) goat anti-rat IgG and CD31 was stained using an affinity
purified anti-mouse CD31 rat IgG followed by Alexa Fluor 488 labeled (green). Images shown are
representative of 3 independent experiments with 3–4 mice each. Magnification of 20X.
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Figure III- 2. Galectin 7-/- mice exhibit reduced survival and increased brain
pathology and parasite burden as the WT mice.
(A) WT and Galectin 7-/- mice were i.c. infected with 60 M. corti and were assessed daily
for disease severity. The survival was monitored for 3 weeks post inoculation. Statistical
comparison of susceptibility was done by Log-rank (Mantel-Cox) Test, P<0.0005***,
n=9-10. (B) Number of parasites at 1wk and 3wk p.i. in parenchymal (P) and extra
parenchymal (EP) regions in individual Galectin 7-/- and WTbrains were calculated by
microscopic examination of serial H&E-stained brain sections. The bars show average +/SEM parasites from 5-6 mice per group. (C) Representative microscopic evaluation of
H&E stained brain cryosections from WT and Galectin 7-/- mice i.c. injected with HBSS
(mock) or with 60 parasites at indicated times p.i.. Magnification 200X. IF microscopy
analysis was performed on brain cryosections from WT and Galectin 7-/- mice i.c.
infected with 60 M. corti parasites to detect TUNEL positive staining (Red). Nuclei
(blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Images are
representative of 5-6 mice in each group from three independent experiments.
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Figure III-3. Galectin 7-/- mice display decreased M2 macrophage accumulation in the
CNS after parasite infection
Brains were isolated from infected WT and Galectin 7-/- and infiltrating cells were
isolated, stained and analyzed using flow cytometry. The cells were stained for
different infiltrating cells. Each bar represents percent cells positive for individual
markers in brains of indicated experimental mice. Data were analyzed using the
flowjo software.
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Figure III- 5. Parasite-infected Galectin 7-/- mice exhibit decreased M2 macrophages
accumulation in brain.
(A) Double immunofluorescence staining was performed on brain cryosections from WT
and Galectin 7-/- mice i.c. injected with HBSS (mock) or with 60 parasites at 1wk .i.c.
Macrophages (MGL-1+) were detected by using an affinity purified anti-mouse MGL1 goat IgG followed by Alexa Fluor® 546 labeled (red). CD11B was stained using
purified CD11B goat IgG followed by Alexa Fluor® 488 labeled (green). Nuclei (blue)
were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Images shown are
representative of 3 independent experiments with 3–4 mice each group. (B) Gating
scheme to select C45hiF4/80+PD-L2 positive cells. Collected cells with gated with
FSC and SCC singlet cells. The cells were then gating on CD45 and F4/80 and PD-L2
positive cells. Representative FACS plots gated on CD45hi, F4/80+ and PD-L2+
(infiltrating M2 macrophages) from individual mouse brain showing cell surface
expression of PD-L2. Results are representative of 3 independent experiments. ***P
<0.005 as determined by t test
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Figure III- 5. Galectin 7 expressing brain endothelial cells regulates M2 trafficking
during NCC infection.
(A) Schema of experimental procedure on adoptive transfer experiment as described in
methods. (B) Purified bone marrow macrophages from WT mice were cultured with
IFN-γ (M1) or Il-4 (M2). The M1 were labeled with CellTracker far-red and M2 with
CellTracker Green CFSE. They mixed in 1:1 ratio and injected intravenously (i.v.) into
WT or Galectin 7−/− recipient mice infected intracranially with M. corti 6 days prior
to injection. Brains were harvested 24 hrs after the adoptive transfer and processed for
flow cytometry. Data shown are mean ± SEM form 9 mice per group in 3 independent.
Statistical significance are denoted by asterisks (*, p<0.05). (B). WT and Galectin 7
brains endothelial cells were isolated and cultured in the upper layer invasion insert
chamber. Upon, differentiation into endothelial cells, the cells were stimulated in the
presence of parasite-derived molecules for 24hrs. BMDM were then incubated into
the top of the chamber. CCL2 is added to the low chamber with media. After 24hrs,
the number of cells that migrated into the lower compartment was counted using
trypan blue. Results are representative of 2 independent experiments Statistical
significance was determined by student t test (* p<0.05).
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Figure III- 6. Inflammatory mediators in the CNS of parasite-infected Galectin 7-/- .
(A) The brains from mock control and M. corti infected WT and Galectin 7−/− mice
were harvested at 1wk .i.c., homogenized, and the protein level of host immune
mediators measured by CBA using flow cytometric analysis (BD Biosciences).
Results shown are mean ± SEM of 3–4 each infected and mock control mice
from 2–3 independent experiments. Statistical significances are denoted by
asterisks (* p<0.05; ** p<0.005). (B) The total RNA was extracted from the
brains at 1wk post inoculation and mRNA expressions of Arginase 1 (ARG 1),
PD-L2, and YM-1 were measured by qRT-PCR as described in Methods. The
fold changes in parasite-infected brains were calculated over the levels in mock
control mice using the formula 2−(ΔΔCt). Data shown are the mean ± SEM of 3–
4 mice per time point in two independent experiments. Significant differences
were measured by Student’s t test (p < 0.005)
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Abstract
Helminth associated with parasitic infections are believed to release glycol-proteins
which modulate the infections process. However, the specific receptors involved and their
function during the parasitic infection, are yet to be completely determined. We examined
the function of galectins, mammalian beta galactose-binding lectins, in a murine model for
neurocysticercosis (NCC) induced by intracranial inoculation of the helminth parasite
Mesocestoides corti. Parasite infection induced multiple galectins, among which Galectin
9 was the first as to be upregulated as well as at a relatively high level in M2. Parasiteinfected Galectin 9-/- mice displayed significantly increased susceptibility to parasite
infection, despite a similar parasite burden in the central nervous system (CNS) compared
to infected wild-type (WT) mice. The accumulation of macrophages, γδ T cells, αβ T cells,
or B cells in the brains of parasite-infected Galectin 9-/- mice was similar to the WT mice.
Moreover, AAMs which play a profound protective role in murine NCC were observed an
increased level in infected WT and Galectin 9-/- mice. Instead, the parasite-infected
Galectin 9-/- mice exhibited a massive neutrophilia in the CNS and an increase in
neutrophil-associated neuroinflammation. These results suggest that galectin 9 may be
involved in controlling and resolving neutrophilia and inflammation, however, not by
efferocytosis. For the first, we showed in the possible correlation between the presence of
Galectin 9 and neutrophilia in NCC infection. Further experiments need to be done to
determine the specific mechanism by which Galectin 9 is involved in this process.
Key words: Galectin 9, neurocysticercosis, neuroinflammation, helminth, CNS infection
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INTRODUCTION
Neurocysticercosis is a common central nervous system (CNS) parasitic disease
caused by the presence of Taenia solium (9, 38). In humans, the infection manifests in a
long asymptomatic phase where the parasite stays in the CNS as a cyst with no detectable
inflammatory response detected surrounding the parasite (4, 11, 33, 40, 42, 43, 58). In
contrast, virtually all the patients with symptomatic disease are characterized by prominent
immunological responses in the brain (4, 58). Indeed, the severity of the symptoms is
associated with the intensity of the immunological response in the CNS microenvironment
(4, 40, 43, 58).
A mouse model of neurocysticercosis by infection with a related cestode
Mesocestoides corti (M. corti), has been used to systematically characterize various aspects
of the host-pathogen response during the entire infection process. In mice, the infection
was found to associate with severe neurological manifestations. A predominant influx of
immune cells consisting of macrophages and γδ T cells (3-5 days p.i), followed by αβ T
cells (1wk p.i) and B-cells (3wk p.i) (141, 154), are differentially recruited into the brain
after parasite inoculation. Furthermore, macrophages with M2-activation (alternative
activation) phenotype of cells are thought to play an important immunological response to
M. corti infection of the CNS as illustrated by the finding that mice deficient in STAT6
exhibit severe CNS pathology with shorter time to death. Importantly, the degree of
leukocyte accumulation in the CNS playing a critical role on neuropathology in the murine
model parallels the results obtained with brain specimens from human patients (40),
suggesting a key role of immune cells in the pathogenesis of the neurocysticercosis.
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Parasitic helminths (worms) in their pursuit to establish long-term infections and
survival in the host use glycans which are abundant on their surface and in their
excretory/secretory products (155, 156) to regulate and suppress host immune responses.
In fact, more than 95% of NCC patients exhibit humoral responses against carbohydratebased antigens which are extensively used for immunodiagnosis of this disease. Indeed,
glycan antigens from the tegument of T. solium and M. corti are found to be released in the
CNS of humans and mice respectively (9, 157). Importantly, glycan antigens with terminal
galactose are released from the parasites and are taken up by the host cells in the CNS
environment in parasite-infected brains (60, 118, 158). Thus lectin receptors that recognize
carbohydrates are likely to be critical in the subsequent immunological events and overall
immunopathogenesis of NCC.
Galectins are important receptors involved in recognition of glycan structures,
particularly containing terminal galactose, on a wide range of molecules in the host or from
pathogens (26, 69-71, 74, 159). Indeed, galectins have been identified as key molecules
that play important roles in cell proliferation, including neural progenitor cells, and
contribute to tissue remodeling during experimental CNS injury (26, 69-71, 74, 160, 161).
Members of galectins have been shown to play diverse roles such as in regulation of
inflammation by sensing necrotic cells (162) or by exhibiting chemoattractant properties
for leukocyte infiltration when secreted extracellularly (163, 164). Given the significant
immunoregulatory role of galectins, the present study is focused on determining the role of
galectin 9 on immunopathogenesis in mouse model of neurocysticercosis. The results
indicate that both galectin 9 play a major role in controlling the initial influx of neutrophils
into the CNS, and providing protection from brain parasite infection.
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Materials and Methods
Mice and parasite inoculation.
Female mice age 4.5 to 6 weeks were used in this study. The C57BL/6 mice were
purchased by Charles River Laboratories, Wilmington, MA. Galectin 9-/- mice were
purchased from Jackson Laboratories. Mesocestoides corti (M. corti) was kindly provided
by Dr. Debrosky Herbert (Cincinnati Children’s Research Foundation, Cincinnati, OH
45229, USA). M. corti metacestodes were maintained in the peritoneal cavity of BALB/c
mice by serial intraperitoneal (i.P.) infection for propagation.
For intracranial infections, M. corti larvae were aseptically collected from the i.p.
the cavity of the infected BALB/c mice and were extensively washed in HBSS. The
metacestodes (about 60 parasites) were suspended in 50 µl of sterile HBSS and injected
intracranially into 4.5 to 6 weeks old female mice using 1 ml syringes and a 25-gauge
needle (10). Control mice were given 50 µl of sterile HBSS. Priority to the inoculation, the
mice were anesthetized with a mixture of xylene (120 µl/ml), ketamine (220 µl/ml) and
PBS. 50 µl of the mixture was given to each mice.
At 1 week and 3 weeks, mice were anesthetized using isoflurane and perfused
through the left ventricle with 20 ml of cold PBS.
Brain mononuclear cell isolation and Flow cytometry
The brain was instantly removed from perfused mice and leukocytes were
processed for antibodies staining for flow cytometry analysis. Briefly, leukocytes single
cells suspensions were isolated from parasite-infected brains of WT and Galectin 9-/- using
percoll density gradient from GE healthcare (CAT# 17-0891-01). The cells were counted
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using trypan blue. 2x106 cells were pre-incubated with Fc blocker for 10min and then
incubated with 50 µl of antibodies cocktail for 30 min. after incubation, the cells were
washed 2 times with 500 µl FACS buffer (10% FBS in PBS) and the pellets were suspended
in 350 µl of FACS buffer and analyzed by BD LSRII flow cytometer (BD Biosciences).
H&E and Immunofluorescence Staining.
Parasite and HBSS infected brains were immediately removed from perfused WT
and Galectin 9-/- mice, embedded in OCT resin and snap frozen. Serial horizontal cryosections with 10um in thickness were positioned on slides (from Sigma-Aldrich, St. Louis,
MO). Every 5th slides were sectioned and stain following the H&E staining protocol
previously described (42). Briefly, the slides were washed twice in deionized water,
dehydrated for 30s in 100% ethanol, stained 30s in hematoxylin, and washed in distilled
water for 2 min (42, 108). Tissue sections were stained with eosin for 15s followed by 2
min treatment with 95 and 100% ethanol each. Slides were allowed to air dry, then
submerged in xylene for 3 min, and mounted using the cytoseal mounting medium
(Stephens Scientific, Riverdale, NJ). The number and location of parasites were determined
by microscopic examination of the stained tissues. Tissues were also analyzed for the
presence or absence of infiltrating leukocytes.
For IF microscopy, the frozen brain tissue sections were stained with relevant
antibodies to detect immune parameters such as galectin 9, and immune cells (107).
Briefly, brain tissue sections were incubated with specific primary antibodies in staining
buffer (PBS buffer with 3% host serum) to prevent non-specific binding. After 45 min of
incubations, sections were washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6 with
0.1% Tween-20 and incubated with appropriate secondary antibodies in staining buffer for
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30 min. Sections were then washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6
with 0.1% Tween-20. For double IF staining, the above-mentioned procedures were
sequentially repeated for each additional staining. The sections were mounted using
FluorSave reagent (Calbiochem, La Jolla, CA) containing 0.3 μM 4’, 6’-diamidino-2phenylindole (DAPI)-diacetate (Molecular Probes). Additional control staining was
performed to rule out any nonspecific staining. In each case, sections were blocked with
saturating concentrations of appropriate host serum antibodies to eliminate false positive
staining due to FcR-mediated nonspecific binding. Staining in the absence of primary
antibodies provided additional negative controls. Primary and secondary antibodies used
for IF staining are: Rabbit anti-galectin 9 (Abcam, San Diego, CA) and Alexa Fluor® 546
or Alexa Fluor® 488 goat anti-rabbit (Molecular Probes, OR), Rat anti-mouse 7/4
(Cedarlane, Burlington, NC) and Alexa Fluor® 546 or Alexa Fluor® 488 Goat anti-rat
(Molecular Probes, OR), and Alexa Fluor® 546 or Alexa Fluor® 488 (Molecular Probes,
OR). We evaluated tissue damage on frozen brain tissue sections from control and parasiteinfected brains by performing the terminal deoxyribonucleotidyl transferase-mediated
triphosphate (dUTP)-biotin nick end labeling (TUNEL) staining as per manufacturer's
instructions (Chemicon International, CA). In all the cases, the images were acquired using
a Nikon eclipse 80i upright microscope (Nikon Corporation, Tokyo, Japan) with an
attached cooled RTke Spot 7.3 three spot color camera (Diagnostic Instruments Inc.,
Sterling Heights, MI). The images were processed and analyzed using Adobe Photoshop
7.0 software (Adobe, Mountain View, CA).
Ex-vivo Efferocytosis
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For these studies, peritoneal neutrophils were isolated from WT mice 12-16hr after
intraperitoneal injection of sterile 4% thioglycollate (BD Biosciences, San Jose, CA) (46).
For macrophages, WT and Galectin 9-/- mice were infected i.p. with M. corti (60-100 in
numbers) and PECs were harvested after 4-5wk p.i. to collect M2 cells. Mock control mice
instead received vehicle (PBS). On day-4 PECs were harvested to purify naïve
macrophages for their role in this process. To obtain neutrophils, WT mice were injected
i.p. with 4% thioglycollate for 16-18 hours.
The purity of the cells was ascertained by flow cytometry analysis (Ly6G+
neutrophils 80-85%; F4/80+ macrophages 85-90%). Isolated neutrophils were labeled with
Carboxyfluorescein succinimidyl ester (CFSE; Cell Trace™ CFSE Cell Proliferation Kit
from Invitrogen). Macrophages seeded on 6 well plates (1x106 cell/ml) were incubated
with CFSE-labeled neutrophils at a ratio of 5:1(neutrophils: macrophages). After 2 hrs of
efferocytosis, non-internalized neutrophils were removed by washing thoroughly.
Macrophages were scraped and stained with F4/80 and Ly6G antibodies for flow
cytometry. Gating scheme to quantitate Ly6G-F4/80+ CFSE+ efferocytic macrophages
that had internalized labeled neutrophils is shown in Figure 8. For individual experiments,
efferocytic index was calculated as percentage of Ly6G-F4/80+CFSE+ macrophages from
WT and Galectin 9-/- mice that engulfed neutrophils (112).
Quantitative Real-Time PCR
Brain from infected and mock control mice 1 week and 3 weeks post infection were
directly perfused and the total RNA was extracted using trizol reagent (Invitrogen)
according to the manufacturer’s instructions. Real-time PCR analysis of the samples was
done using SYBRO green (Applied Biosystems, CA (USA). Transcript levels of the
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housekeeping ribosomal 18S, Galectin 9.genes were measured in each sample by PCR
amplification

using

specific

primers.:

removed

18S

(forward)

5'-

CATGTGGTGTTGAGGAAAGCA-3' and (reverse) 5'-GTCGTGGGTTCTGCATGATG3'; Gal-9 (forward) 5'- TCAAGGTGATGGTGAACAAGAAA-3’ and (reverse) 5’GATGGTGTCCACGAGGTGGTA -3’
Statistical Analysis
The survival of the infected WT and Galectin 9-/-mice was compared using Logrank (Mantel-Cox) Test. The statistical comparison between levels of host mediators was
done with Student's t test using Sigma Plot 8.
Results
Predominant expression of galectin 9 in macrophages and astrocytes in the CNS after
M. corti infection.
Quantitative real-time PCR analysis was performed to determine the expression
profile of galectins in mock-infected and parasite-infected brain. Upon infection, gene
expression of several galectins was significantly upregulated. Among them, galectin 9
mRNA expression was significantly upregulated at 1wk p.i. (~7-fold) and at 3wk p.i. (~3fold) (Figure.IV-1A). Next, in situ IF microscopy analyses were performed to determine
the expression and distribution of galectin 9 at the protein level in brain tissues from mockinfected control mice and in mice undergoing neurocysticercosis. In the uninfected
animals, galectin 9 expression was largely undetected (Figure.IV-1B). At both 1wk and
3wk p.i. approximately half of the immune cells present in meninges and ventricles were
positive for galectin 9 protein (Figure.IV-1B). Double immunofluorescence analysis with
anti-galectin 9 and antibodies to cell surface markers specific for various immune cells
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indicated that the majority of cells detected positive for galectin 9 were CD11b positive
myeloid cells detected in the intraparenchymal areas of CNS (Figure.IV-1B).
Morphological, anatomical correlation, and colocalization staining strongly suggested that
the upregulated galectin 9 at protein level was mainly detected in infiltrating myeloid cells.
However, with the progression of infection time, some the astrocytes and their foot
processes proximal to the pial vessels showed galectin 9 positive staining (data not shown).
Galectin 9-/- mice are more susceptible to parasite infection in murine NCC
To investigate whether galectin 9 deficiency influences the overall immunity during
the CNS infection with M. corti, disease severity was compared between WT and Galectin
9-/- mice. The WT mice injected i.c. with M. corti displayed typical neurological signs
including abnormal vestibular function, tilted head, cerebral abnormalities, morbidity, and
weight loss between 1-3wk p.i. In general, these overt signs appeared earlier and were more
accentuated in Galectin 9-/- mice. In addition, infected Galectin 9-/- mice exhibited
decreased survival. By 7wk post-M. corti infection, 25% of M. corti-infected WT mice
succumbed to the infection compared to 70% of Galectin 9-/- mice (Figure.IV- 2A, p<0.05).
Galectin 9 deficiency has no effect on parasite load in infected
To examine whether increased disease severity in galectin 9- deficient mice was
associated with less effective control of parasite growth, serial horizontal sections of
infected WT and Galectin 9-/- brains of mice were stained with H&E, and the number of
M. corti metacestodes was determined by microscopic analysis. Both WT and Galectin 9/-

mice exhibited similar numbers of parasites as compared to the infected brains of WT

mice both early (1wk) and later (3wk) (Figure.IV- 2B) post-M. corti infection, suggesting
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that galectin 9 dependenting responses have no influence on overall parasite growth in the
CNS.
Galectin 9-/- mice exhibit increased accumulation of neutrophils in parasite-infected
brains
Galectin 9-/- mice exhibited increased susceptibility to murine NCC. To investigate
whether galectin 9 deficiency had any effect on immunopathological events, H&E staining
was performed to determine immunopathological changes in WT and Galectin 9-/- mice at
3wk p.i. (Figure.IV- 3A) depicts normal brain tissue morphology in WT and Galectin 9-/control animals i.c. inoculated with HBSS. In contrast, a large number of infiltrating
immune cells was observed in both parasite infected WT (Figure.IV-3A) and Galectin 9-/mice (Figure.IV-3A). In parasite infected WT mice, a high proportion of infiltrating cells
appeared to be myeloid (Figure.IV- 3B, inset), whereas in Galectin 9-/- mice the
predominant cell type was polymorphonuclear cells (PMNs) (Figure.IV- 3A, inset). Next,
using IF microscopy, the presence of neutrophils was analyzed at 3 wks after parasite
inoculation. In wild-type mice, neutrophils (7/4+ cells) were scarcely detected in the brain
at 3wk of parasite inoculation (Figure.IV- 3A). In contrast, the immune response revealed
the presence of large numbers of 7/4+ neutrophils (Figure.IV- 3B) associated with the
infiltrates in extra-parenchymal regions (ventricles, meninges, and subarachnoid spaces) at
3wk p.i (Figure.IV- 3B).
The flow-cytometry analysis was performed to quantify the differences in the levels
of neutrophils recruited into the CNS of Galectin 9-/- and WT infected mice. The differences
in recruitment of neutrophils in Galectin 9-/- mice were analyzed at both an early stage of
infection (1 wk p.i.) and at the peak of inflammation (3 wk p.i.) (Figure.IV- 3C). M. corti
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infection in both WT and Galectin 9-/- mice resulted in infiltration of similar numbers of
CD11b+ly6G+ activated neutrophils at 1wk p.i. (Figure.IV- 3C). However, at 3wk p.i.
infected Galectin 9-/- mice displayed significantly increased numbers of CD11b+Ly6G+
neutrophil cells as compared to the WT infected mice (Figure.IV- 3C). Thus, taken
together, the histopathological and flow cytometric analyses demonstrate that absence of
galectin 9 leads to a significant increase in neutrophils recruitment into the brain during
NCC, particularly at the peak of inflammation.
Inflammatory cytokines and chemokines expression in the CNS after M. corti
infection.
To determine whether Galectin 9-/- mice exhibit differences in immune mediators
in the CNS during M. corti infection, the protein level of various cytokines, chemokines,
and several other signature mediators were analyzed by CBA analysis. In infected Galectin
9-/- mice, both IL-10 and IL-17 were detected at a lower level in the CNS at 1wk p.i.,
whereas a reduced IL-5 was detected in these mice at 3wk p.i. compared to the WT mice
(Figure.IV- 4). To our surprise, in general, there were no significant differences between
WT and Galectin 9-/- mice observed in the CNS levels of majority of the immune mediators
analyzed (Figure.IV- 4). Moreover, the absence of galectin 9 did not appear to significantly
influence the CNS level of neutrophil chemoattractants (CXCL1), neutrophil survival
mediator (GM-CSF) in the parasite-infected- Galectin 9-/- mice as compared to the WT
infected mice.
Galectin 9-deficiency has no effect on efferocytic clearance of neutrophils.
To determine the mechanism of neutrophils accumulation in the CNS of M. corti
infected Galectin 9-/- mice, we examined the possible role of galectin 9 in neutrophil
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clearance by efferocytosis. Macrophages from WT and Galectin 9-/- mice with or without
infection with M .croti were exposed to CFSE–labeled dead neutrophils from WT mice in
vitro. Flow-cytometric analysis was performed to measure the frequency of the Ly6GF4/80+CFSE+ cells, which represent the efferocytic macrophages that have internalized
CFSE labeled neutrophils. The uptake of neutrophils by macrophages from Galectin 9-/mice did not display any significant difference in comparison with the macrophage from
WT mice. The results indicated that galectin 9 on macrophages does not participate in
neutrophils clearance. Thus, a higher neutrophil accumulation in Galectin 9-/- brains is
unlikely due to any defect in their efferocytic clearance by macrophages.
Discussion
Parasites express both nonhost-like and host-like glycan antigens (29). The
expression of host-like glycans by parasitic helminths is widespread, and different hostlike glycans are found in a broad range of parasites (13, 91, 102, 118). It is thus no surprise
that there is ever increasing evidence supporting a role for lectins, the glycan binding
receptors, in immune functions. Because lectin receptors have been implicated in a wide
variety of immunological functions including first-line defense against pathogens, cell
trafficking, cell differentiation and immune regulation (26, 67, 71-73, 103, 165), a better
understanding of their involvement in CNS immunopathogenesis might lead to the
identification of novel therapeutic strategies against neuropathological conditions. Here we
found that galactose-binding lectin galectin 9 is upregulated robustly within 7 days of
infection in the CNS of mice infected i.c. with M. corti. We hypothesized that this early
upregulation of galectin 9 is involved in providing necessary signals for regulating the
immune responses in the CNS parasite-infected mice. Indeed, the results from present
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studies strongly support the influence of galectin 9 on the host immune response affecting
the pathogenesis of the CNS parasitic disease.
Infection of the CNS by M. corti is characterized by the initial accumulation of
parasites and inflammatory cells in extra-parenchymal areas of the brain, which include
ventricles, meninges, and subarachnoid spaces. Macrophages represent the predominant
leukocyte populations in the parasite-infected brain both initially and during prolonged
infection (7, 81, 166, 167). In contrast, among the infiltrating immune cells, neutrophils
are detected at a very low level both early and at later times of infection in the CNS during
murine neurocysticercosis (33). To our surprise, we saw a larger accumulation of
neutrophils in the CNS at the peak of inflammation (3wk p.i.) in M. corti-infected galectin
9-deficient mice. Neutrophil-mediated responses are essential for combating microbial
infection, however, their direct role in protection to helminth parasite infections is limited.
Persistent accumulation of neutrophils can lead to bystander tissue destruction, owing to
their noxious cargo (168). Thus, it is likely that the increased accumulation of neutrophils
in the CNS of parasite-infected Galectin 9-/- mice is contributing to the exacerbated disease
severity. Furthermore, the fact that most of the hyper-inflammatory mediators detected at
similar level correlating with an unchanged parasite burden, further supports a direct effect
of neutrophil-associated tissue damaging mediators contributing to the mortality of
Galectin 9-/- mice. However, if galectin 9 absence eventuates in increased nervous tissue
pathology in parasite-infected Galectin 9-/- mice remains to be determined.
Accumulation of large numbers of neutrophils in the CNS microenvironment of
parasite-infected Galectin 9-/- mice could either be due to modulation of expression of
associated inflammatory mediators; due to a defect in their clearance by efferocytosis; or a
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combination of both. Indeed, accumulating evidence suggests galectins can function as
pattern recognition receptors (PRRs) in innate immunity as they bind both endogenous
glycans as well as bind exogenous glycans on the surface of potentially pathogenic
microbes, parasites, and fungi (50, 84). However, our findings strongly suggest galectin 9
is unlikely functioning as a PRR in regulating neutrophil turnover in the CNS
microenvironment. If galectin 9 is functioning as a PRR, we would expect to observe a
significantly upregulated expression of chemokines and cytokines involved in neutrophil
functions in the CNS of Galectin 9-/- mice. Instead, we found no significant difference in
the level of neutrophil chemoattractants (CXCL1) and neutrophil survival mediators (GMCSF) in brain homogenates of parasite-infected WT and Galectin 9-/- mice. Moreover, IL17 was detected at a reduced level in the CNS of Galectin 9-/- mice at 3wk p.i. As IL-17
activates pathway involved in neutrophils recruitment, our results further suggest an unlike
role of Galectin 9 as a PRR, whose activation by parasite molecules controls the neutrophil
recruitment. On the other hand, we also found no difference in efferocytic clearance of
neutrophils by galectin 9 deficient macrophages from Galectin 9-/- mice inoculated with M.
corti or PBS. In similar settings, deficiency of another related galectin, the galectin 3 on
macrophages significantly decreases their capacity to efferocytosis neutrophils. Indeed,
accumulation of large numbers of neutrophils in the brains of parasite-infected Galectin 3/-

mice is due to a defect in efferocytic clearance of neutrophils by the galectin 3 deficient

macrophages. In light of no observed role of galectin 9 as PRR or in efferocytosis, we are
currently investigating a possible novel role of this lectin as a negative regulator of
neutrophil influx into the CNS by performing adoptive transfer experiment. Relevant to
our hypothesis, mouse MGL that binds galactose and galactosamine containing glycans,
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has been reported to impede migration of immature dendritic cells (DCs) (112) as well as
neutrophils (112). Indeed, MGL-1 has recently shown by us to negatively regulate
neutrophils infiltration into the lungs of Klebsiella pneumonia infected mice (112). In toto,
notwithstanding the mechanisms involved, this study shows that galectin 9 plays an
important role in negatively regulating the neutrophil influx into the CNS, which can have
major implications in the therapeutic measurements of inflammation associated CNS
disorders.

Figure.IV- 1: Expression and distribution of galectin 9 in the parasite-infected
brains
(A) The total RNA was extracted from the brains at 1wk and 3wk post inoculation and
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mRNA expression of galectin 9 was measured by qRT-PCR as described in Methods.
The fold changes in parasite-infected brains were calculated over the levels in mock
control mice using the formula 2−(ΔΔCt). Data shown are the mean ± SEM of 3–4
mice per time point in two independent experiments. (B) Double immunofluorescence
staining was performed on brain tissue cryosections from mock or parasite- infected
C57/BL6 mice. Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindoledilactate (DAPI). Galectin 9 was stained using an affinity purified anti-mouse galectin
9 goat IgG followed by Alexa Fluor® 546 labeled (Red) Goat anti-Rabbit IgG. galectin
9 expression was co-visualized with macrophages using an affinity purified anti-mouse
CD11B Alexa Fluor® 488 labeled (Green). Images shown are representative of 3
independent experiments with 3–4 mice each. Magnification of 20X

Figure.IV- 2: Galectin 9-/- mice exhibit reduced survival and increased brain
pathology despite exhibiting similar parasite burden as the WT mice.
(A) WT and Galectin 9-/- mice were i.c. infected with 60 M. corti and were assessed
daily for disease severity. The survival was monitored for 3 weeks post inoculation.
Statistical comparison of susceptibility was done by Log-rank (Mantel-Cox),
P<0.05,n=9-10. (B) Number of parasites at 1wk and 3wk p.i. in parenchymal (P) and
106

extra parenchymal (EP) regions in individual Galectin 9-/- and WT brains were
calculated by microscopic examination of serial H&E-stained brain sections. The bars
show average +/- SEM parasites from 5-6 mice per group

Figure.IV- 3: Parasite-infected Galectin 9-/- mice exhibit increased neutrophil
accumulation in brain.
IF microscopy on brain cryosections from WT and Galectin 9-/- mice i.c. injected with
HBSS (mock) or with 60 parasites at 1wk and 3wk p.i. Neutrophils (7/4+) were detected
by using an affinity purified anti-mouse 7/4 goat IgG followed by Alexa Fluor® 546
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labeled (red). Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate
(DAPI). Images shown are representative of 3 independent experiments with 3–4 mice
each group. (B) Flow cytometry analysis of CD11b and Ly6G on brain mononuclear cells
harvested from mock control and M. corti infected WT and Galectin 9-/- mice at 1wk and
3wk p.i. The cells were double-stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue
antibodies as markers for neutrophils. Representative contour plots show CD11b+Ly6G+
neutrophils in brains of parasite-infected WT and Galectin 9-/- mice. The bar graph on
the right shows mean ± SEM of percent of CD11b+Ly6G+ neutrophils in brains of M. corti
infected WT and Galectin 9-/- mice each from 3 independent experiments.

Figure.IV- 4: Inflammatory mediators in the CNS of parasite-infected Galectin 9-/and WT mice.
(A) The brains from mock control and M. corti infected WT and Galectin 9-/- mice
were harvested at 1wk and 3wk p.i., homogenized, and the protein level of host
immune mediators measured by CBA using flow cytometric analysis (BD
Biosciences). Results shown are mean ± SEM of 3–4 each infected and mock control
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mice from 2–3 independent experiments. Statistical significances are denoted by
asterisks (*, p<0.05; **, p<0.005).

Figure.IV- 5: Galectin 9-/- M2-macrophage do not exhibit defect in efferocytosis of
neutrophils ex-vivo.
WT and Galectin 9-/- mice were either infected with M. corti , or PBS.( A) Efferocytosis
of CFSE+ neutrophils by macrophages from WT and Galectin 9-/- mock control mice that
received vehicle (M0-PBS) or M. corti parasite (M2- M. corti) intraperitoneally. The
percent of Ly6G-F4/80+CFSE+ macrophages that have internalized CFSE labeled
neutrophils are shown by the scatter plot.
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CHAPTER V
GENERAL DISCUSSION
The major goal of these studies was to elucidate the protective correlates in NCC, focusing
on mechanisms shaping trafficking of M2 macrophages into the CNS, and effector
molecules expressed in M2 cells regulating CNS immunopathology. As in most other
neuroinflammatory diseases, clinical presentations of NCC are thought to be influenced by
chronic inflammatory responses causing neuropathology. In the absence of a classically
defined lymphatic system in the CNS, macrophages and microglia functions as innate
immune responders to infection. The initial recognition of microbial molecules by these
cells induce the initial local inflammatory response and effector functions as well as
shaping the subsequent pathogen-specific adaptive immune response. In this regard, it has
been established that the M1 inflammatory functional phenotype in macrophages/
microglia generally promote the destruction of microbial pathogens, but also can cause
widespread nervous tissue damage as well as impair CNS repair process (93). In contrast,
emerging evidence suggests that M2 activation phenotype of these cells promote nervous
tissue repair and restoration (95, 96, 99). However, direct mechanistic evidence showing
the protective function of M2- macrophages/ microglia in the CNS microenvironment is
limited. In addition, mechanisms specifically involved in M2 macrophage infiltration into
the CNS is yet to be understood. In this regard, our work has shown before that in mouse
model of NCC, M2 macrophages are first to infiltrate into the parasite-infected CNS. They
seemed to play essential/ necessary roles in containing neuropathology and disease severity
as the reduced number of cells with M2 activation phenotype in the CNS of STAT6-/- mice
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was associated with heightened disease severity (none of the mice survived after 2wk p.i.).
The objective of the proposed studies was to elucidate the M2 associated protective
correlates in mouse model of NCC, focusing on; a) characterizing the mechanism/s
regulating trafficking of M2 macrophages into the parasite-infected CNS, and b) effector
molecules expressed in M2 cells regulating CNS immunopathology. In this regard, a
growing body of evidence indicates that glycans from a number of pathogens including
helminths act as PAMPs. Previous studies have shown that M. corti parasite infection is
associated with the release of glycans in the CNS microenvironment. Particularly, the
parasites release glycans containing terminal galactose/ galactosamine, both robustly and
early during infection (40). In this study, we extended these findings and analyzed the
expression and distribution of galectins, which are the most common PRRs that recognize
galactose containing molecules, in normal and parasite-infected brains. We found a
upregulate expression of galectin 3 and galectin 9 (infiltrating macrophages), and galectin
7 (brain endothelial cells) in the parasite-infected brains. Our initial first hypothesis was
that galectin 3 and galectin 9 expressed in M2 macrophages would contribute to the M2
macrophages –mediated anti-inflammatory, immune-regulatory, and/ or tissue-protective
responses to prevent the inflammation-induced pathology in parasite-infected brains. Our
second hypothesis was that the parasite-infection induced expression of galectin 7 on brain
endothelial cells would influence the trafficking of M2 macrophages into the CNS.

Although, galectin 3 have been detected in both immune cells, including dendritic
cells, macrophages, and neutrophils (5, 50, 51, 53, 169) and nervous tissue cells such as
microglia and astrocytes during different infection (57), in the helminth infected brains
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galectin 3 was specifically detected in the cytosol of infiltrating M2 macrophages. Galectin
3 has been demonstrated with diverse functions in host immunity. It acts both as PRRs to
recognize pathogen structures but also can function by itself as a danger-associated
molecular pattern (DAMP). It modulates the migration of immune cells to the sites of
inflammation as well as augment the effector functions of these infiltrating immune cells.
The diverse functions of galectin 3 thought to due to the difference in its cellular
localization (extracellular, membrane-bound, or cytoplasmic), oligomerization, as well as
the molecules it interacts with (72, 78, 103, 120). It has been shown to involve in bacterial
clearance by macrophages (5) as well as modulating dendritic cells function to parasite
infection (169). The importance of the galectin 3 in host immunity and pathogenesis is
evident in several clinical settings. For example, infections of Galectin 3-/- mice in
microbial infection involving Streptococcus pneumonia, H. pylori, and E. coli resulted in
more severe disease outcome. Interestingly, the increased disease severity of Galectin 3-/infected with Streptococcus pneumonia and H. pylori was due to the reduced neutrophil
trafficking in the absence of galectin 3 contributing to an impairment of pathogen
clearance. In contrast, we recently showed in F. novicida infection galectin 3 function as
DAMP/ alarmin, and a reduced neutrophilic inflammation in Galectin 3-/- mice was
correlated with reduced pathology and improved survival compared to the excessive
inflammation associated sepsis signs in WT infected mice. Similarly, infection with
Leishmania major, an intracellular parasite, an impaired neutrophil response and reduced
inflammatory cytokine production contributes to an increase in parasite burden and
susceptibility in Galectin 3-/- mice (170). In a model of a different parasitic infection,
infection of mice with Toxoplasma gondii, galectin 3-deficient mice showed a reduced
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inflammatory response with increased parasite burden in both systemic organs as well as
in brain, correlated with an increased disease severity in them as compared to the infected
WT mice (171). Thus, galectin 3 seems to play a role in promoting inflammation, including
neutrophil-mediated response that improves survival to microscopic bacterial and parasitic
infections. However, the results from our experiments demonstrated that deficiency of
galectin 3 leads to increased accumulation of neutrophils and M2 macrophages in the
helminth infected brains correlated with increased neuropathology and overall disease
outcome. Importantly, the adoptive transfer of M2 macrophages from WT mice into
Galectin 3-/- NCC mice reduced CNS inflammation in terms of decreased neutrophils
accumulation, which coincided with lower infiltrating immune cell death. Thus, it is likely
during infection with macroscopic helminth parasites, the abundant expression of galectin
3 in M2 macrophages controls the neutrophilic accumulation. In the absence of galectin 3
mediated function of M2 macrophages in reducing neutrophil accumulation leads to tissue
pathology. Due to the sensitive nature of the nervous tissue, neutrophil-associated
pathology in the absence of galectin 3 in M2 macrophages leads to severe clinical
symptoms with fatal consequences in murine NCC.
One of the possibilities for the observed increased accumulation of neutrophils in
the CNS of parasite-infected Galectin 3-/- mice could be due to a defect in efferocytosis of
neutrophils by Galectin 3-/- M2 macrophages. This is somewhat supported by a recent study
showing galectin 3 secreted by neutrophils facilitates efferocytosis of these cells by
interacting with its ligand on macrophage surface (61). However, the data from our studies
clearly suggested that galectin 3 in the cytosol of M2 macrophages regulates neutrophil
turnover possibly by efferocytosis in the CNS microenvironment. In this regard,
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efferocytosis is an important process by which phagocytic cells engulf and clear apoptotic
cells (172-175). The multi-step efferocytosis process involves recognition of “find me”
signals/ molecules presented by apoptotic cells. Some these “find me” molecules are ATP,
UTP, CX3CL1, and lipid lysophosphatidylcholine (LPC), which allow the phagocytes cells
to migrate towards the apoptotic cells. Some of the well-characterized receptors on
macrophages such as P2Y2 receptor and G2A facilitates phagocytic cells interaction with
these “Find me” signals (172-176). However, expression of “eat me” signals on the dying/
dead cells such as the phosphatidylserine (PS) by the phagocytic cells lead to uptake of the
dying/ dead cells by phagocytes (172-176). In this regard, receptors such as Tim-3, Tim-4,
as well as Stabilin 2 have been known to interact with the “eat me” ligands, and leading to
the cytoskeleton rearrangement and internalization of the dying cells showed that Galectin
3 plays a critical role in the clearance of dead neutrophils during NCC. Efferocytosis in
critical to control inflammation. Although, the data from our studies clearly suggested a
key role for galectin 3 in M2 macrophages associated efferocytosis, however, the
mechanisms involved needs to be identified.
During murine NCC, similar to the galectin 3 expression profile, galectin 9 was
primarily expressed in the infiltrating myeloid cells. We speculated that galectin 9 will
function similarly as galectin 3 in regulating neutrophil turnover and associated
inflammatory pathology. This was also supported by some of our recent works involving
F. novicida intranasal infection, where both galectin 3 and galectin 9 found to function as
alarmins and mice deficient of either galectin 3 or galectin 9 intra-nasally infected with F.
novicida, displayed reduced neutrophil accumulation and tissue pathology in the lungs
(107, 177). This was correlated with a decreased systemic inflammation and improved
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survival in Galectin 3-/- and Galectin 9-/- mice. Similar to our findings in Galectin 3-/- NCC
mice discussed above, an increased accumulation of neutrophils in the CNS of parasiteinfected Galectin 9-/- mice, albeit the effect was relatively less pronounced as compared to
that observed with galectin 3 deficiency. Moreover, infected Galectin 9-/- mice displayed
higher neuropathology and increased susceptibility to M. corti infection of the CNS.
Mechanistically, however, in contrast to the role of galectin 3 in M2-macrophage mediated
efferocytosis, M2 macrophages from Galectin 9-/- mice displayed no defect in efferocytosis
of neutrophils. Notwithstanding the mechanisms involved, galectin 9 promotes antiinflammatory/ immune-regulatory role by controlling neutrophils turnover in the parasiteinfected CNS to prevent the inflammation-induced pathology. Perhaps, Galectin 9 by
binding to its ligand Tim-3 or CD44 facilitates apoptotic clearance of neutrophils as
observed for galectin 9 mediated immune cell clearance reported in other pathological
settings (8, 63). Indeed, neutrophils express both CD44 and Tim-3 on their surface. Another
possibility is that galectin 9 presence on neutrophil surface regulates its turnover and
thereby contributing to the observed disease severity in galectin 9-deficient mice.
A considerable body of evidence supports the view that microglia/macrophages are potent
modulators of the outcome of neuropathological conditions such as in brain infections,
stroke, traumatic brain injury, and spinal cord injury (5, 6). For instance, M2 macrophage/
microglia-induced response is thought to be important in nervous tissue repair as well as
containment of neuropathology. However, most of our knowledge of these important
findings are derived from in vitro studies or in vivo studies where M2 cells are depleted
using chemicals. Here using a murine model of NCC, we further provided direct
mechanistic evidence showing the protective function of M2- macrophages to decrease
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neuropathology and improved mortality during CNS helminth infection. Galectin 7 plays
an important role in initial influx of M2 macrophages into the CNS as indicated by reduced
numbers of these cells observed in the CNS microenvironment of the parasite-infected
Galectin 7-/- mice. Importantly, adoptive transfer of galectin 7+/+ (WT) M2 macrophages
failed to migrate into the CNS of parasite-infected galectin 7-deficient mice further
indicating galectin 7 as a central regulator of M2 cells transmigration into the CNS. The
findings suggests that galectin 7 on brain endothelial cells a critical role in regulating M2macrophages influx into the CNS, and in its absence the reduced accumulation of M2 cells
contribute to the lethality of Galectin 7-/- mice, may offer important mechanisms to target
in CNS inflammatory disease conditions. On the other hand, galectin 3 and galectin 9
upregulation were found predominantly in infiltrating macrophages and infiltrating
myeloid cells respectively. As an increased neutrophilia was observed in the CNS of
Galectin 3-/- and Galectin 9 mice, suggesting they play immune regulatory functions in the
CNS microenvironment. In toto, our studies make an important contribution in establishing
the novel protective mechanisms of M2 macrophages functions in the CNS pathological
conditions. Our studies provide a better understanding of the immunopathogenesis of NCC
which should lead to new therapeutic strategies in other CNS inflammatory disorders as
well.
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Figure.V: Working model

Murine NCC are believed to release parasitic glycans in the CNS microenvironment. The
glycans induce the differential expression of galectins that recognize galactose moieties, in
endothelial cells play a critical role in immunopathology by modulating trafficking of M2
macrophages into the CNS, whereas galectins expressed in M2 cells controls the protective
functions of these cell types including Nervous tissue repair, preventing NCS pathology
and controlling disease severity.
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